{"content":"<li class=\"n-box-item date-title\" data-end=\"1562990399\" data-start=\"1562904000\" data-txt=\"Monday, December 23, 2019\">Friday, July 12, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3477558\" data-ts=\"1562969058\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTST\" target=\"_blank\">CTST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477558-canntrust-faces-inspection-over-minor-issues-vaughan-facility\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CannTrust faces inspection over &#39;minor issues&#39; at Vaughan facility</a></h4><ul>   <li>CannTrust (NYSE:<a href='https://seekingalpha.com/symbol/CTST' title='CannTrust Holdings Inc.'>CTST</a>) CEO Peter Aceto tells Bloomberg that regulators are inspecting its facility in Vaughan, Ontario, over \"minor issues\" around space licensing.</li>    <li>Health Canada inspectors had found the company grew pot in unlicensed rooms in a greenhouse in Pelham, Ontario.</li>    <li>\"We\u2019re growing very, very rapidly and we just need to make sure that cannabis is in properly licensed rooms, so we voluntarily disclosed some minor issues with regards to that,\" Aceto told the news service.</li>    <li>One employee was terminated in connection with the breach.</li>    <li>It's place a hold on sales and shipments but doesn't believe there are any health issues of concern.</li>    <li>Shares are <font color=\"red\">down 1.6%</font> postmarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477558\" data-linked=\"CannTrust faces inspection over &#39;minor issues&#39; at Vaughan facility\" data-tweet=\"$CTST - CannTrust faces inspection over &#39;minor issues&#39; at Vaughan facility https://seekingalpha.com/news/3477558-canntrust-faces-inspection-over-minor-issues-vaughan-facility?source=tweet\" data-url=\"https://seekingalpha.com/news/3477558-canntrust-faces-inspection-over-minor-issues-vaughan-facility\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477554\" data-ts=\"1562966995\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477554-lptx-eqm-eton-and-ua-among-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LPTX, EQM, ETON and UA among after hour movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics, Inc.'>LPTX</a> <font color=\"green\">+5.58%</font>. <a href='https://seekingalpha.com/symbol/EQM' title='EQM Midstream Partners, LP'>EQM</a> <font color=\"green\">+4.22%</font>. <a href='https://seekingalpha.com/symbol/ITUB' title='Itaú Unibanco Holding S.A.'>ITUB</a> <font color=\"green\">+2.46%</font>. <a href='https://seekingalpha.com/symbol/GYB' title='CABCO Trust Floating Rate Callable Ctfs 2004-15.02.34 Ser 2004-101 on 6.345% Cap Secs 34Goldman'>GYB</a> <font color=\"green\">+2.25%</font>. <a href='https://seekingalpha.com/symbol/RYAAY' title='Ryanair Holdings plc'>RYAAY</a> <font color=\"green\">+2.12%</font>.</li><li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/ETON' title='Eton Pharmaceuticals, Inc.'>ETON</a> <font color=\"red\">-14.46%</font>. <a href='https://seekingalpha.com/symbol/UA' title='Under Armour, Inc.'>UA</a> <font color=\"red\">-5.14%</font>. <a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color=\"red\">-2.29%</font>. <a href='https://seekingalpha.com/symbol/SEMG' title='SemGroup Corporation'>SEMG</a> <font color=\"red\">-2.15%</font>. <a href='https://seekingalpha.com/symbol/NBRV' title='Nabriva Therapeutics plc'>NBRV</a> <font color=\"red\">-2.07%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477554\" data-linked=\"LPTX, EQM, ETON and UA among after hour movers\" data-tweet=\"$LPTX $EQM $ITUB - LPTX, EQM, ETON and UA among after hour movers https://seekingalpha.com/news/3477554-lptx-eqm-eton-and-ua-among-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3477554-lptx-eqm-eton-and-ua-among-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477549\" data-ts=\"1562965138\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477549-long-oil-funds-lead-list-of-etf-gainers-this-week\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Long oil funds lead list of ETF gainers this week</a></h4><ul><li><strong>Gainers: </strong>Crude Daily 3X Long Proshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>) <font color=\"green\">+13.9%</font>. Ultrapro Crude Oil Proshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/OILU' title='ProShares UltraPro 3x Crude Oil ETF'>OILU</a>) <font color=\"green\">+13.8%</font>. United States 3X Oil Fund (NYSEARCA:<a href='https://seekingalpha.com/symbol/USOU' title='United States 3x Oil Fund'>USOU</a>) <font color=\"green\">+13.7%</font>. Velocity 3X Long Crude Oil (NYSEARCA:<a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>) <font color=\"green\">+13.6%</font>. Direxion Junior Gold Mine Bull 3X (NYSEARCA:<a href='https://seekingalpha.com/symbol/JNUG' title='Direxion Daily Junior Gold Miners Index Bull 3x Shares ETF'>JNUG</a>) <font color=\"green\">+9.9%</font>.</li><li><strong>Losers: </strong>Ultrapro Short Crude Oil Proshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/OILD' title='ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>) <font color=\"red\">-13.7%</font>. Crude Daily -3X Inverse Proshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>) <font color=\"red\">-13.6%</font>. Velocity 3X Inverse Crude Oil (NYSEARCA:<a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>) <font color=\"red\">-13.6%</font>. United States 3X Short Oil Fund (NYSEARCA:<a href='https://seekingalpha.com/symbol/USOD' title='United States 3x Short Oil Fund ETF'>USOD</a>) <font color=\"red\">-13.4%</font>. Ultrapro Biotechnology Proshares (NASDAQ:<a href='https://seekingalpha.com/symbol/UBIO' title='ProShares UltraPro NASDAQ Biotechnology ETF'>UBIO</a>) <font color=\"red\">-10.4%</font>.</li><li><strong>Top non-leveraged gainers: </strong>Alps ETF Trust Sprott Junior Gold (NYSEARCA:<a href='https://seekingalpha.com/symbol/SGDJ' title='Sprott Junior Gold Miners ETF'>SGDJ</a>) <font color=\"green\">+4.9%</font>. US Healthcare Providers Ishares ETF  (NYSEARCA:<a href='https://seekingalpha.com/symbol/IHF' title='iShares U.S. Healthcare Providers ETF'>IHF</a>) <font color=\"green\">+4.8%</font>. US Oil Fund (NYSEARCA:<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>) <font color=\"green\">+4.8%</font>. Ipath.B S&amp;P GSCI Crude Oil (NYSEARCA:<a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>) <font color=\"green\">+4.7%</font>. G-X Gold Explorers ETF  (NYSEARCA:<a href='https://seekingalpha.com/symbol/GOEX' title='Global X Gold Explorers ETF'>GOEX</a>) <font color=\"green\">+4.4%</font>.</li><li><strong>Top non-leveraged losers: </strong>Advisorshares Pure Cannabis ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/YOLO' title='AdvisorShares Pure Cannabis ETF'>YOLO</a>) <font color=\"red\">-9.2%</font>. Alternative Harvest ETF  (NYSEARCA:<a href='https://seekingalpha.com/symbol/MJ' title='ETFMG Alternative Harvest ETF'>MJ</a>) <font color=\"red\">-7.2%</font>. G-X FTSE Greece 20 ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/GREK' title='Global X MSCI Greece ETF'>GREK</a>) <font color=\"red\">-4.9%</font>. Rare Earth/Strategic Metals Vaneck ETF  (NYSEARCA:<a href='https://seekingalpha.com/symbol/REMX' title='VanEck Vectors Rare Earth/Strategic Metals ETF'>REMX</a>) <font color=\"red\">-4.2%</font>. Db-Xt Harvest CSI 500 China A (NYSEARCA:<a href='https://seekingalpha.com/symbol/ASHS' title='Deutsche X-trackers Harvest CSI 500 China-A Shares Small Cap ETF'>ASHS</a>) <font color=\"red\">-3.9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477549\" data-linked=\"Long oil funds lead list of ETF gainers this week\" data-tweet=\"$WTIU $OILU $USOU - Long oil funds lead list of ETF gainers this week https://seekingalpha.com/news/3477549-long-oil-funds-lead-list-of-etf-gainers-this-week?source=tweet\" data-url=\"https://seekingalpha.com/news/3477549-long-oil-funds-lead-list-of-etf-gainers-this-week\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477543\" data-ts=\"1562963780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLEX\" target=\"_blank\">FLEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477543-flex-pharma-stockholders-back-salarius-merger-shares-up-15-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Flex Pharma stockholders back Salarius merger; shares up 15% after hours</a></h4><ul><li>At its special meeting, Flex Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/FLKS' title='Flex Pharma, Inc.'>FLKS</a>) stockholders <a href=\"https://seekingalpha.com/pr/17570399-flex-pharma-announces-approval-merger-related-proposals-special-meeting\" target=\"_blank\">voted in favor</a> of all merger-related proposals associated with its planned tie-up with Salarius Pharmaceuticals <a href=\"https://seekingalpha.com/news/3420638-flex-pharma-44-percent-merger-salarius-pharmaceuticals\" target=\"_blank\">announced </a>in January. The transaction should close in the coming weeks.</li><li>The combined company will do business as Salarius Pharmaceuticals.</li><li>Shares are up <font color=\"green\">15%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477543\" data-linked=\"Flex Pharma stockholders back Salarius merger; shares up 15% after hours\" data-tweet=\"$FLEX $SLRX - Flex Pharma stockholders back Salarius merger; shares up 15% after hours https://seekingalpha.com/news/3477543-flex-pharma-stockholders-back-salarius-merger-shares-up-15-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3477543-flex-pharma-stockholders-back-salarius-merger-shares-up-15-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477534\" data-ts=\"1562962658\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETON\" target=\"_blank\">ETON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477534-eton-down-13-after-hours-on-crl-for-emminus-100\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eton down 13% after hours on CRL for EM-100</a></h4><ul><li>Eton Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ETON' title='Eton Pharmaceuticals, Inc.'>ETON</a>) <a href=\"https://seekingalpha.com/pr/17570393-eton-pharmaceuticals-provides-update-emminus-100-program\" target=\"_blank\">announces </a>that its partner [a subsidiary of Bausch Health Companies (NYSE:<a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a>) per a February 19 <a href=\"https://www.prnewswire.com/news-releases/bausch-health-acquires-eton-pharmaceuticals-em-100-investigational-eye-drop-for-the-treatment-of-itchy-eyes-associated-with-allergies-300797699.html\" target=\"_blank\">press release</a>] received a Complete Response Letter &#40;CRL&#41; from the FDA regarding the partner's marketing application seeking approval for EM-100, an eye drop for the potential treatment of ocular itching associated with allergic conjunctivitis.</li><li>Eton says the CRL did not cite the need for additional clinical data but offered no additional information other than stating that a response will be submitted shortly, adding that it remains confident that the agency will approve the product.</li><li>The Bausch subsidiary acquired the U.S. rights to EM-100 in February.</li><li>ETON is down <font color=\"red\">13%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477534\" data-linked=\"Eton down 13% after hours on CRL for EM-100\" data-tweet=\"$ETON $BHC - Eton down 13% after hours on CRL for EM-100 https://seekingalpha.com/news/3477534-eton-down-13-after-hours-on-crl-for-emminus-100?source=tweet\" data-url=\"https://seekingalpha.com/news/3477534-eton-down-13-after-hours-on-crl-for-emminus-100\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477518\" data-ts=\"1562957903\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477518-vvpr-uxin-pt-and-omcl-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VVPR, UXIN, PT and OMCL among tech movers</a></h4><ul><li><b>Gainers:</b> VivoPower International (NASDAQ:<a href='https://seekingalpha.com/symbol/VVPR' title='VivoPower International PLC'>VVPR</a>) <font color=\"green\">+15%</font>. Uxin (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin Limited'>UXIN</a>) <font color=\"green\">+12%</font>. Daqo New Energy (NYSE:<a href='https://seekingalpha.com/symbol/DQ' title='Daqo New Energy Corp.'>DQ</a>) <font color=\"green\">+10%</font>. Luokung Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/LKCO' title='Luokung Technology Corp.'>LKCO</a>) <font color=\"green\">+10%</font>. Ooma (NYSE:<a href='https://seekingalpha.com/symbol/OOMA' title='Ooma, Inc.'>OOMA</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers:</b> Pintec Technology Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PT' title='Pintec Technology Holdings Limited'>PT</a>) <font color=\"red\">-11%</font>. EMCORE (NASDAQ:<a href='https://seekingalpha.com/symbol/EMKR' title='EMCORE Corporation'>EMKR</a>) <font color=\"red\">-10%</font>. Omnicell (NASDAQ:<a href='https://seekingalpha.com/symbol/OMCL' title='Omnicell, Inc.'>OMCL</a>) <font color=\"red\">-9%</font>. Vislink Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/VISL' title='Vislink Technologies, Inc.'>VISL</a>) <font color=\"red\">-8%</font>. Himax Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HIMX' title='Himax Technologies, Inc.'>HIMX</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477518\" data-linked=\"VVPR, UXIN, PT and OMCL among tech movers\" data-tweet=\"$VVPR $UXIN $DQ - VVPR, UXIN, PT and OMCL among tech movers https://seekingalpha.com/news/3477518-vvpr-uxin-pt-and-omcl-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3477518-vvpr-uxin-pt-and-omcl-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477516\" data-ts=\"1562957723\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UPL\" target=\"_blank\">UPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477516-ultra-petroleum-nixes-exchange-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ultra Petroleum nixes exchange offer</a></h4><ul><li>Ultra Petroleum (<a href='https://seekingalpha.com/symbol/UPL' title='Ultra Petroleum Corp.'>UPL</a> <font color='green'>+15.3%</font>) moves higher after <a href=\"https://seekingalpha.com/pr/17569886-ultra-petroleum-corp-announces-termination-exchange-offer-7_125-percent-senior-notes-due-2025\" target=\"_blank\">terminating its offer</a> to exchange outstanding 7.125% senior notes due 2025 of its Ultra Resources unit for new 9.00% cash or 2.50% payment-in-kind senior secured third lien notes due 2024 to be issued by the same unit.</li><li>UPL had extended the original May 23 deadline for the exchange several times since its <a href=\"https://seekingalpha.com/pr/17506177-ultra-petroleum-corp-announces-commencement-exchange-offer-7_125-percent-senior-notes-due\" target=\"_blank\">initial announcement</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477516\" data-linked=\"Ultra Petroleum nixes exchange offer\" data-tweet=\"$UPL $UPLC - Ultra Petroleum nixes exchange offer https://seekingalpha.com/news/3477516-ultra-petroleum-nixes-exchange-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3477516-ultra-petroleum-nixes-exchange-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477515\" data-ts=\"1562957581\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLAY\" target=\"_blank\">PLAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477515-dave-busters-adds-to-buyback-firepower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dave &amp; Buster&#39;s adds to buyback firepower</a></h4><ul> <li>Dave &amp; Buster's Entertainment (<a href='https://seekingalpha.com/symbol/PLAY' title='Dave & Buster&#39;s Entertainment, Inc.'>PLAY</a> <font color='green'>+2.8%</font>) says its board authorized the repurchase of an additional $200M in buybacks under the existing repurchase program through the end of FY20.</li><li>All other terms of the share repurchase program remain in effect.</li><li>The company now has a total share repurchase authorization of $800M. As of July 11, the company had repurchased 3.1 M shares for $135M this year.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17570354-dave-and-buster-s-announces-additional-share-repurchase-authorization-200-million\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3477515\" data-linked=\"Dave &amp; Buster&#39;s adds to buyback firepower\" data-tweet=\"$PLAY - Dave &amp; Buster&#39;s adds to buyback firepower https://seekingalpha.com/news/3477515-dave-busters-adds-to-buyback-firepower?source=tweet\" data-url=\"https://seekingalpha.com/news/3477515-dave-busters-adds-to-buyback-firepower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477513\" data-ts=\"1562956669\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MT\" target=\"_blank\">MT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477513-arcelormittal-italia-declares-force-majeure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArcelorMittal Italia declares force majeure</a></h4><ul><li>ArcelorMittal's (<a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color=\"green\">+3.1%</font>) Italian unit <a href=\"https://www.argusmedia.com/en/news/1938852-arcelormittal-italia-declares-force-majeure\" target=\"_blank\">declares force majeure</a> following a crane accident Wednesday at its Taranto works.</li><li>MT says the declaration follows authorities' seizure of pier No. 4 at the Taranto works in part of an investigation of the accident.</li><li>Stoppages of the facility's blast furnacess have affected 10K-12K tons/day of production, Argus reports, citing market participants.</li><li>The Taranto works, formerly operated by Ilva and acquired by  MT last year, is Italy's largest flat products works; it was  expected to produce ~5M metric tons of flat products in 2019, up  from 4.5M mt last year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477513\" data-linked=\"ArcelorMittal Italia declares force majeure\" data-tweet=\"$MT - ArcelorMittal Italia declares force majeure https://seekingalpha.com/news/3477513-arcelormittal-italia-declares-force-majeure?source=tweet\" data-url=\"https://seekingalpha.com/news/3477513-arcelormittal-italia-declares-force-majeure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477512\" data-ts=\"1562955555\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UAL\" target=\"_blank\">UAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477512-united-extends-expected-return-of-737-max-until-least-november\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United extends expected return of 737 MAX until at least November</a></h4><ul><li>United Airlines (<a href='https://seekingalpha.com/symbol/UAL' title='United Airlines Holdings, Inc.'>UAL</a> <font color=\"green\">+2%</font>) says the Boeing 737 MAX (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color=\"green\">+1.6%</font>) will <a href=\"https://uk.reuters.com/article/us-ethiopia-airplane-ual/boeing-737-max-to-remain-off-united-airlines-schedule-until-november-3-idUKKCN1U728T\" target=\"_blank\">stay off its flight schedule until Nov. 3</a>, after previously leaving its 14 737 MAX jets off its flight schedule through early September.</li><li>The decision was expected after Boeing said late last month that it likely would take until at least September to fix a fresh flaw in the grounded  737 MAX discovered by the Federal Aviation Administration.</li><li>Among other U.S. MAX operators, Southwest so far has  canceled flights through Oct. 1 and American through  Sept. 3, though those timelines also likely will be extended.</li><li>The longer the MAX grounding lasts, the more strain on airlines counting on  fresh deliveries of the plane this year to renew and expand  their fleets; UAL was expecting a total of 30 MAX jets by year-end,  meaning that its daily flight cancellations are increasing for every  month that the aircraft is grounded.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477512\" data-linked=\"United extends expected return of 737 MAX until at least November\" data-tweet=\"$UAL $BA - United extends expected return of 737 MAX until at least November https://seekingalpha.com/news/3477512-united-extends-expected-return-of-737-max-until-least-november?source=tweet\" data-url=\"https://seekingalpha.com/news/3477512-united-extends-expected-return-of-737-max-until-least-november\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477509\" data-ts=\"1562954497\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477509-camber-energy-and-quintana-energy-services-among-energy-materials-gainers-energy-fuels-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Camber Energy and Quintana Energy Services among Energy/Materials gainers; Energy Fuels and Uranium Energy among losers</a></h4><ul><li><b>Gainers: </b>Camber Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/CEI' title='Camber Energy, Inc.'>CEI</a>) <font color=\"green\">+34%</font>. Quintana Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/QES' title='Quintana Energy Services Inc.'>QES</a>) <font color=\"green\">+12%</font>. New Gold (NYSEMKT:<a href='https://seekingalpha.com/symbol/NGD' title='New Gold Inc.'>NGD</a>) <font color=\"green\">+9%</font>. NexGen Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/NXE' title='NexGen Energy Ltd.'>NXE</a>) <font color=\"green\">+9%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Energy Fuels (NYSEMKT:<a href='https://seekingalpha.com/symbol/UUUU' title='Energy Fuels Inc.'>UUUU</a>) <font color=\"red\">-37%</font>. Uranium Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/UEC' title='Uranium Energy Corp.'>UEC</a>) <font color=\"red\">-34%</font>. SenesTech (NASDAQ:<a href='https://seekingalpha.com/symbol/SNES' title='SenesTech, Inc.'>SNES</a>) <font color=\"red\">-13%</font>. MV Oil Trust (NYSE:<a href='https://seekingalpha.com/symbol/MVO' title='MV Oil Trust'>MVO</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477509\" data-linked=\"Camber Energy and Quintana Energy Services among Energy/Materials gainers; Energy Fuels and Uranium Energy among losers\" data-tweet=\"$CEI $QES $NGD - Camber Energy and Quintana Energy Services among Energy/Materials gainers; Energy Fuels and Uranium Energy among losers https://seekingalpha.com/news/3477509-camber-energy-and-quintana-energy-services-among-energy-materials-gainers-energy-fuels-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3477509-camber-energy-and-quintana-energy-services-among-energy-materials-gainers-energy-fuels-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477506\" data-ts=\"1562953656\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OHRP\" target=\"_blank\">OHRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477506-ohr-pharma-and-neubase-complete-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ohr Pharma and NeuBase complete merger</a></h4><ul><li>Ohr Pharmaceuticals (<a href='https://seekingalpha.com/symbol/OHRP' title='OHR Pharmaceutical, Inc.'>OHRP</a> <font color=\"green\">+16.4%</font>) and NeuBase Therapeutics have completed their <a href=\"https://seekingalpha.com/pr/17570164-neubase-therapeutics-closes-merger-transaction-ohr-pharmaceutical\" target=\"_blank\">merger</a>, first <a href=\"https://seekingalpha.com/news/3420242-ohr-pharmaceutical-plus-82-percent-announcing-merger-neubase-therapeutics\" target=\"_blank\">announced </a>in January.</li><li>The combined company will do business as Neubase Therapeutics and will trade under the ticker \"NBSE\" starting Monday, July 15.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477506\" data-linked=\"Ohr Pharma and NeuBase complete merger\" data-tweet=\"$OHRP $NBSE - Ohr Pharma and NeuBase complete merger https://seekingalpha.com/news/3477506-ohr-pharma-and-neubase-complete-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3477506-ohr-pharma-and-neubase-complete-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477504\" data-ts=\"1562952246\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477504-ilmn-uuuu-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ILMN, UUUU among midday movers</a></h4><ul><li><b>Gainers</b>: Tower International (NYSE:<a href='https://seekingalpha.com/symbol/TOWR' title='Tower International, Inc.'>TOWR</a>) <font color=\"green\">+69%</font>. Camber Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/CEI' title='Camber Energy, Inc.'>CEI</a>) <font color=\"green\">+50%</font>. HOOKIPA Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/HOOK' title='HOOKIPA Pharma Inc.'>HOOK</a>) <font color=\"green\">+28%</font>. Milacron Holdings  (NYSE:<a href='https://seekingalpha.com/symbol/MCRN' title='Milacron Holdings Corp.'>MCRN</a>) <font color=\"green\">+25%</font>. VivoPower International PLC (NASDAQ:<a href='https://seekingalpha.com/symbol/VVPR' title='VivoPower International PLC'>VVPR</a>) <font color=\"green\">+21%</font>. ProQR Therapeutics N.V. (NASDAQ:<a href='https://seekingalpha.com/symbol/PRQR' title='ProQR Therapeutics N.V.'>PRQR</a>) <font color=\"green\">+21%</font>. Oasmia Pharmaceutical AB (NASDAQ:<a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical AB &#40;publ&#41;'>OASM</a>) <font color=\"green\">+20%</font>. MediciNova (NASDAQ:<a href='https://seekingalpha.com/symbol/MNOV' title='MediciNova, Inc.'>MNOV</a>) <font color=\"green\">+17%</font>. Medigus (NASDAQ:<a href='https://seekingalpha.com/symbol/MDGS' title='Medigus Ltd.'>MDGS</a>) <font color=\"green\">+16%</font>. Uxin (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin Limited'>UXIN</a>) <font color=\"green\">+14%</font>.</li><li><b>Losers: </b>Energy Fuels (NYSEMKT:<a href='https://seekingalpha.com/symbol/UUUU' title='Energy Fuels Inc.'>UUUU</a>) <font color=\"red\">-35%</font>. Uranium Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/UEC' title='Uranium Energy Corp.'>UEC</a>) <font color=\"red\">-27%</font>. Hebron Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/HEBT' title='Hebron Technology Co., Ltd.'>HEBT</a>) <font color=\"red\">-17%</font>. Illumina (NASDAQ:<a href='https://seekingalpha.com/symbol/ILMN' title='Illumina, Inc.'>ILMN</a>) <font color=\"red\">-16%</font>. U.S. Xpress Enterprises (NYSE:<a href='https://seekingalpha.com/symbol/USX' title='U.S. Xpress Enterprises, Inc.'>USX</a>) <font color=\"red\">-14%</font>. Co-Diagnostics (NASDAQ:<a href='https://seekingalpha.com/symbol/CODX' title='Co-Diagnostics, Inc.'>CODX</a>) <font color=\"red\">-13%</font>. CannTrust Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CTST' title='CannTrust Holdings Inc.'>CTST</a>) <font color=\"red\">-12%</font>. Sigma Labs (NASDAQ:<a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a>) <font color=\"red\">-12%</font>. Hillenbrand (NYSE:<a href='https://seekingalpha.com/symbol/HI' title='Hillenbrand, Inc.'>HI</a>) <font color=\"red\">-12%</font>. SenesTech, Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/SNES' title='SenesTech, Inc.'>SNES</a>) <font color=\"red\">-12%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477504\" data-linked=\"ILMN, UUUU among midday movers\" data-tweet=\"$TOWR $CEI $HOOK - ILMN, UUUU among midday movers https://seekingalpha.com/news/3477504-ilmn-uuuu-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3477504-ilmn-uuuu-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477503\" data-ts=\"1562952060\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDP\" target=\"_blank\">FDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477503-fresh-del-monte-lower-after-salmonella-probe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fresh Del Monte lower after Salmonella probe</a></h4><ul> <li>Fresh Del Monte (NYSE:<a href='https://seekingalpha.com/symbol/FDP' title='Fresh Del Monte Produce Inc.'>FDP</a>) is <font color=\"red\">down 4.76%</font> amid reports of an investigation into the company over a salmonella outbreak with its vegetable trays back in May.</li><li><a href=\"https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-salmonella-infantis-linked-del-monte-vegetable-trays-spring-2019\" target=\"_blank\">FDA statement</a></li>   </ul><div class=\"tiny-share-widget\" data-id=\"3477503\" data-linked=\"Fresh Del Monte lower after Salmonella probe\" data-tweet=\"$FDP - Fresh Del Monte lower after Salmonella probe https://seekingalpha.com/news/3477503-fresh-del-monte-lower-after-salmonella-probe?source=tweet\" data-url=\"https://seekingalpha.com/news/3477503-fresh-del-monte-lower-after-salmonella-probe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477502\" data-ts=\"1562951943\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRY\" target=\"_blank\">TLRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477502-pot-stocks-continue-sell-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pot stocks continue sell-off</a></h4><ul><li>Cannabis producers continue their downward path. Most are down substantially this year as investors continue to sober up with their valuations.</li><li>Selected tickers: Tilray (<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color=\"red\">-2.9%</font>), Aurora Cannabis (<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a> <font color=\"red\">-4.3%</font>), Cronos Group (<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group Inc.'>CRON</a> <font color=\"red\">-6.1%</font>), Canopy Growth (<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a> <font color=\"red\">-7%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3477502\" data-linked=\"Pot stocks continue sell-off\" data-tweet=\"$TLRY $ACB $CRON - Pot stocks continue sell-off https://seekingalpha.com/news/3477502-pot-stocks-continue-sell-off?source=tweet\" data-url=\"https://seekingalpha.com/news/3477502-pot-stocks-continue-sell-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>186&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477500\" data-ts=\"1562951460\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSP\" target=\"_blank\">SSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477500-scripps-prices-upsized-500m-debt-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scripps prices upsized $500M debt offering</a></h4><ul>    <li>E.W. Scripps (<a href=\"http://seekingalpha.com/symbol/SSP\" target=\"_blank\">SSP</a> <font color=\"green\">+3.1%</font>) has <a href=\"https://seekingalpha.com/pr/17570294-scripps-prices-senior-notes-offering\" target=\"_blank\">priced a $500M debt offering</a> through its Scripps Escrow subsidiary.</li>    <li>The amount is an upsizing from plans for a $400M offering of 5.875% senior notes due 2027. They're priced at 100% in a private offering.</li>    <li>The company boosted the size of the offering due to strong demand and favorable pricing.</li>    <li>The escrow issuer will merge into the company on the closing of Scripps' $580M acquisition of eight stations from Nexstar Media Group, tied to that company's acquisition of Tribune Media.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477500\" data-linked=\"Scripps prices upsized $500M debt offering\" data-tweet=\"$SSP - Scripps prices upsized $500M debt offering https://seekingalpha.com/news/3477500-scripps-prices-upsized-500m-debt-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3477500-scripps-prices-upsized-500m-debt-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477499\" data-ts=\"1562951076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477499-loop-industries-and-flexshopper-only-financial-gainers-puyi-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Loop Industries and FlexShopper the only financial gainers; Puyi among losers</a></h4><ul><li><b>Gainers:</b> Loop Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/LOOP' title='Loop Industries, Inc.'>LOOP</a>) <font color=\"green\">+10%</font>. FlexShopper (NASDAQ:<a href='https://seekingalpha.com/symbol/FPAY' title='FlexShopper, Inc.'>FPAY</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers:</b> Innovative Industrial Properties (NYSE:<a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties, Inc.'>IIPR</a>) <font color=\"red\">-11%</font>. Noah Holdings (NYSE:<a href='https://seekingalpha.com/symbol/NOAH' title='Noah Holdings Limited'>NOAH</a>) <font color=\"red\">-6%</font>. Puyi (NASDAQ:<a href='https://seekingalpha.com/symbol/PUYI' title='Puyi Inc.'>PUYI</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477499\" data-linked=\"Loop Industries and FlexShopper the only financial gainers; Puyi among losers\" data-tweet=\"$LOOP $FPAY $IIPR - Loop Industries and FlexShopper the only financial gainers; Puyi among losers https://seekingalpha.com/news/3477499-loop-industries-and-flexshopper-only-financial-gainers-puyi-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3477499-loop-industries-and-flexshopper-only-financial-gainers-puyi-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477497\" data-ts=\"1562950978\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477497-milacron-and-nf-energy-saving-among-industrial-gainers-hebron-technology-and-hillenbrand\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Milacron and NF Energy Saving among Industrial gainers; Hebron Technology and Hillenbrand among losers</a></h4><ul><li><b>Gainers: </b>Milacron (NYSE:<a href='https://seekingalpha.com/symbol/MCRN' title='Milacron Holdings Corp.'>MCRN</a>) <font color=\"green\">+24%</font>. NF Energy Saving (NASDAQ:<a href='https://seekingalpha.com/symbol/BIMI' title='NF Energy Saving Corporation'>BIMI</a>) <font color=\"green\">+19%</font>. Energy Recovery (NASDAQ:<a href='https://seekingalpha.com/symbol/ERII' title='Energy Recovery, Inc.'>ERII</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Hebron Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/HEBT' title='Hebron Technology Co., Ltd.'>HEBT</a>) <font color=\"red\">-18%</font>. Hillenbrand (NYSE:<a href='https://seekingalpha.com/symbol/HI' title='Hillenbrand, Inc.'>HI</a>) <font color=\"red\">-12%</font>. Intelligent Systems (NYSEMKT:<a href='https://seekingalpha.com/symbol/INS' title='Intelligent Systems Corporation'>INS</a>) <font color=\"red\">-7%</font>. Boise Cascade (NYSE:<a href='https://seekingalpha.com/symbol/BCC' title='Boise Cascade Company'>BCC</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477497\" data-linked=\"Milacron and NF Energy Saving among Industrial gainers; Hebron Technology and Hillenbrand among losers\" data-tweet=\"$MCRN $ERII $HEBT - Milacron and NF Energy Saving among Industrial gainers; Hebron Technology and Hillenbrand among losers https://seekingalpha.com/news/3477497-milacron-and-nf-energy-saving-among-industrial-gainers-hebron-technology-and-hillenbrand?source=tweet\" data-url=\"https://seekingalpha.com/news/3477497-milacron-and-nf-energy-saving-among-industrial-gainers-hebron-technology-and-hillenbrand\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477492\" data-ts=\"1562949699\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CFMS\" target=\"_blank\">CFMS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477492-conformis-eases-5-after-archon-share-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ConforMIS eases 5% after Archon share sale</a></h4><ul><li>ConforMIS (<a href='https://seekingalpha.com/symbol/CFMS' title='Conformis, Inc.'>CFMS</a> <font color=\"red\">-5.1%</font>) slips on below-average volume in apparent reaction to a <a href=\"https://www.sec.gov/Archives/edgar/data/1305773/000091957419004574/xslF345X03/ownership.xml\" target=\"_blank\">disclosure </a>by top stockholder Archon Capital Management that it sold ~702K shares at an average price of $3.79.</li><li>Shares are currently exchanging hands at $3.54.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477492\" data-linked=\"ConforMIS eases 5% after Archon share sale\" data-tweet=\"$CFMS - ConforMIS eases 5% after Archon share sale https://seekingalpha.com/news/3477492-conformis-eases-5-after-archon-share-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3477492-conformis-eases-5-after-archon-share-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477490\" data-ts=\"1562948618\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UUUU\" target=\"_blank\">UUUU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477490-trump-reportedly-will-not-support-uranium-export-quotas\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trump reportedly will not support uranium export quotas</a></h4><ul><li>U.S. uranium miners plunge as Pres. Trump reportedly has decided to <a href=\"https://www.afr.com/news/world/north-america/australian-uranium-exporters-winners-as-trump-dumps-quota-plan-20190712-p526l8\" target=\"_blank\">make no changes</a> to rules governing uranium supply.</li><li>Energy Fuels (<a href='https://seekingalpha.com/symbol/UUUU' title='Energy Fuels Inc.'>UUUU</a> <font color=\"red\">-31.3%</font>) and Ur-Energy (<a href='https://seekingalpha.com/symbol/URG' title='Ur-Energy Inc.'>URG</a> <font color=\"red\">-29.3%</font>) had <a href=\"https://seekingalpha.com/news/3477301-uranium-miners-ready-ramp-trump-oks-quotas\" target=\"_blank\">petitioned for quotas</a> requiring 25% of the U.S. uranium market be sourced domestically; also, <a href='https://seekingalpha.com/symbol/UEC' title='Uranium Energy Corp.'>UEC</a> <font color=\"red\">-18.4%</font>.</li><li>Trump is understood to have been dissuaded from imposing a quota because of concerns it would drive up costs for nuclear reactor operators who already are under pressure from providers of cheaper sources of power such as natural gas and renewables, according to <em>Australian Financial Review</em>.</li><li>Canadian-based uranium miners are higher: <a href='https://seekingalpha.com/symbol/CCJ' title='Cameco Corporation'>CCJ</a> <font color=\"green\">+3.1%</font>, <a href='https://seekingalpha.com/symbol/DNN' title='Denison Mines Corp.'>DNN</a> <font color=\"green\">+4.3%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/URA' title='Global X Uranium ETF'>URA</a>, <a href='https://seekingalpha.com/symbol/NLR' title='VanEck Vectors Uranium+Nuclear Energy ETF'>NLR</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3477490\" data-linked=\"Trump reportedly will not support uranium export quotas\" data-tweet=\"$UUUU $URG $UEC - Trump reportedly will not support uranium export quotas https://seekingalpha.com/news/3477490-trump-reportedly-will-not-support-uranium-export-quotas?source=tweet\" data-url=\"https://seekingalpha.com/news/3477490-trump-reportedly-will-not-support-uranium-export-quotas\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>331&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477489\" data-ts=\"1562948609\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477489-altice-usa-meets-fcc-on-sprint-t-mobile-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altice USA meets with FCC on Sprint/T-Mobile deal</a></h4><ul>     <li>Altice USA (<a href=\"http://seekingalpha.com/symbol/ATUS\" target=\"_blank\">ATUS</a> <font color=\"green\">+2.1%</font>) is the latest company to <a href=\"https://ecfsapi.fcc.gov/file/1071193453259/Altice%20USA%20Inc.%20-%207.9.19%20Meeting.pdf\" target=\"_blank\">come in for a meeting</a> with the FCC's transaction team handling the proposed $26.5B merger of Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color=\"green\">+2%</font>) and T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"green\">+1.1%</font>).</li>    <li>Altice reiterated its prior advocacy and, according to its filing, discussed \"commitments necessary from New T-Mobile to preserve sustainable competitive entry into the retail wireless market for the benefit of consumers.\"</li>    <li>The review of the deal is at day 221 on an informal 180-day FCC timeline, but the deal has all but formal approval from a majority of FCC members; the focus now is on <a href=\"https://seekingalpha.com/news/3477170-t-mobile-sprint-slide-report-merger-slowed\" target=\"_blank\">Justice Dept. negotiations</a> focused on enabling a fourth national wireless carrier.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477489\" data-linked=\"Altice USA meets with FCC on Sprint/T-Mobile deal\" data-tweet=\"$ATUS $S $TMUS - Altice USA meets with FCC on Sprint/T-Mobile deal https://seekingalpha.com/news/3477489-altice-usa-meets-fcc-on-sprint-t-mobile-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3477489-altice-usa-meets-fcc-on-sprint-t-mobile-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477484\" data-ts=\"1562947406\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477484-tower-international-and-tenneco-among-consumer-gainers-village-farms-international-and-vuzix\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tower International and Tenneco among Consumer gainers; Village Farms International and Vuzix among losers</a></h4><ul><li><b>Gainers: </b>Tower International (NYSE:<a href='https://seekingalpha.com/symbol/TOWR' title='Tower International, Inc.'>TOWR</a>) <font color=\"green\">+69%</font>. Tenneco (NYSE:<a href='https://seekingalpha.com/symbol/TEN' title='Tenneco Inc.'>TEN</a>) <font color=\"green\">+9%</font>. Lydall (NYSE:<a href='https://seekingalpha.com/symbol/LDL' title='Lydall, Inc.'>LDL</a>) <font color=\"green\">+7%</font>. Lindblad Expeditions (NASDAQ:<a href='https://seekingalpha.com/symbol/LIND' title='Lindblad Expeditions Holdings, Inc.'>LIND</a>) <font color=\"green\">+5%</font>. Cooper-Standard (NYSE:<a href='https://seekingalpha.com/symbol/CPS' title='Cooper-Standard Holdings Inc.'>CPS</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Village Farms International (NASDAQ:<a href='https://seekingalpha.com/symbol/VFF' title='Village Farms International, Inc.'>VFF</a>) <font color=\"red\">-6%</font>. Vuzix (NASDAQ:<a href='https://seekingalpha.com/symbol/VUZI' title='Vuzix Corporation'>VUZI</a>) <font color=\"red\">-6%</font>. Fresh Del Monte Produce (NYSE:<a href='https://seekingalpha.com/symbol/FDP' title='Fresh Del Monte Produce Inc.'>FDP</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477484\" data-linked=\"Tower International and Tenneco among Consumer gainers; Village Farms International and Vuzix among losers\" data-tweet=\"$TOWR $TEN $LDL - Tower International and Tenneco among Consumer gainers; Village Farms International and Vuzix among losers https://seekingalpha.com/news/3477484-tower-international-and-tenneco-among-consumer-gainers-village-farms-international-and-vuzix?source=tweet\" data-url=\"https://seekingalpha.com/news/3477484-tower-international-and-tenneco-among-consumer-gainers-village-farms-international-and-vuzix\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477482\" data-ts=\"1562947147\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477482-j-and-j-down-5-on-criminal-probe-baby-powder-asbestos-claims\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J&amp;J down 5% on criminal probe into baby powder asbestos claims</a></h4><ul><li>Johnson &amp; Johnson (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color=\"red\">-4.6%</font>) is down on below-average volume in apparent response to the <a href=\"https://www.zerohedge.com/news/2019-07-12/jj-shares-tumble-report-asbestos-talc-criminal-probe\" target=\"_blank\">news </a>that the U.S. Department of Justice is pursuing a criminal investigation against the company related to its alleged misleading of the public about the possible cancer risks of its talcum powder products.</li><li>The company is already mired in thousands of lawsuits from consumers who attribute their cancers to said products.</li><li>The company has repeatedly denied any wrongdoing.</li><li><strong>Update</strong>: A Washington grand jury is <a href=\"https://news.bloomberglaw.com/product-liability-and-toxics-law/j-j-denials-of-asbestos-in-baby-powder-spur-criminal-probe-1\" target=\"_blank\">examining </a>company documents related to what it knew about the potential cancer risks. Company scientists allegedly wrote memos some years ago warning of the risks.</li><li><strong>Update</strong>: Reuters <a href=\"https://www.reuters.com/article/us-johnson-johnson-talc-probe/jj-faces-u-s-criminal-probe-related-to-baby-powder-bloomberg-idUSKCN1U726J\" target=\"_blank\">reports</a> that the company said that there have no new developments in the matter. It disclosed the receipt of subpoenas from the Justice Department and SEC in its most recent 10-K in February.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477482\" data-linked=\"J&amp;J down 5% on criminal probe into baby powder asbestos claims\" data-tweet=\"$JNJ - J&amp;J down 5% on criminal probe into baby powder asbestos claims https://seekingalpha.com/news/3477482-j-and-j-down-5-on-criminal-probe-baby-powder-asbestos-claims?source=tweet\" data-url=\"https://seekingalpha.com/news/3477482-j-and-j-down-5-on-criminal-probe-baby-powder-asbestos-claims\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>208&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477476\" data-ts=\"1562945819\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNNHF\" target=\"_blank\">VNNHF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477476-brazil-court-ruling-clears-way-for-belo-suns-amazon-mine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brazil court ruling clears way for Belo Sun&#39;s Amazon mine</a></h4><ul><li>Belo Sun Mining (<a href='https://seekingalpha.com/symbol/VNNHF' title='Belo Sun Mining Corp'>OTCPK:VNNHF</a> <font color='green'>+4.7%</font>) says it <a href=\"https://www.reuters.com/article/us-belo-sun-ming-brazil/canadas-belo-sun-touts-brazil-court-ruling-clearing-way-for-gold-mine-idUSKCN1U71WX\" target=\"_blank\">won a key legal victory</a> in its efforts to build a gold mine in the Amazon rain forest, which has drawn criticism from environmentalists and indigenous advocates.</li><li>The Canadian miner says a Brazilian appeals court ruled the Para state is the appropriate authority to grant an environmental license for the project; prosecutors had argued the mine needed a license from federal regulators.</li><li>Belo Sun already has received state licensing but still must deliver a new study on the impact on nearby indigenous communities of the project, which would be Brazil's largest gold mine.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477476\" data-linked=\"Brazil court ruling clears way for Belo Sun&#39;s Amazon mine\" data-tweet=\"$VNNHF - Brazil court ruling clears way for Belo Sun&#39;s Amazon mine https://seekingalpha.com/news/3477476-brazil-court-ruling-clears-way-for-belo-suns-amazon-mine?source=tweet\" data-url=\"https://seekingalpha.com/news/3477476-brazil-court-ruling-clears-way-for-belo-suns-amazon-mine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477475\" data-ts=\"1562945504\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNK\" target=\"_blank\">MNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477475-mallinckrodt-bonds-slip-after-400m-draw-from-revolver\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mallinckrodt bonds slip after $400M draw from revolver</a></h4><ul><li>Mallinckrodt's (<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt plc'>MNK</a> <font color=\"green\">+4.4%</font>) 4.75% notes due 2023 and 5.625% notes due 2023 are under modest pressure after indirect subsidiary MEH, Inc. <a href=\"https://www.sec.gov/Archives/edgar/data/1567892/000156789219000030/mnk8-k071119.htm\" target=\"_blank\">borrowed $400M</a> under its revolving credit facility. The transaction leaves $95M in available funds for borrowing.</li><li>It says that it borrowed the $400M to increase liquidity (focused on debt reduction) ahead of its planned <a href=\"https://seekingalpha.com/news/3467081-mallinckrodt-advancing-business-split-shares-1-percent-premarket\" target=\"_blank\">spin-off</a> of its specialty generics/AGI business to shareholders.</li><li>The company bought back $302.2M of debt in Q2 (total of $669.1M since September 28, 2018).</li></ul><div class=\"tiny-share-widget\" data-id=\"3477475\" data-linked=\"Mallinckrodt bonds slip after $400M draw from revolver\" data-tweet=\"$MNK - Mallinckrodt bonds slip after $400M draw from revolver https://seekingalpha.com/news/3477475-mallinckrodt-bonds-slip-after-400m-draw-from-revolver?source=tweet\" data-url=\"https://seekingalpha.com/news/3477475-mallinckrodt-bonds-slip-after-400m-draw-from-revolver\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477467\" data-ts=\"1562944208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRQR\" target=\"_blank\">PRQR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477467-proqr-up-13-ahead-of-qrminus-421a-presentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ProQR up 13% ahead of QR-421a presentation</a></h4><ul><li>ProQR Therapeutics N.V. (<a href='https://seekingalpha.com/symbol/PRQR' title='ProQR Therapeutics N.V.'>PRQR</a> <font color=\"green\">+12.9%</font>) is up on slightly higher volume ahead of a <a href=\"https://seekingalpha.com/pr/17561308-proqr-announces-presentation-qrminus-421a-program-ophthalmology-usher-syndrome-coalition\" target=\"_blank\">presentation </a>on candidate QR-421a in Usher syndrome tomorrow at the Annual Usher Connections Conference in Philadelphia.</li><li>QR-421a is an investigational RNA-based therapeutic designed to exclude exon 13 from the USH2A gene's messenger RNA, thereby removing the mutation that causes retinitis pigmentosa associated with Usher syndrome type 2.</li><li><a href=\"https://ghr.nlm.nih.gov/condition/usher-syndrome\" target=\"_blank\">Usher syndrome</a> is an inherited disorder characterized by hearing and vision loss that worsens over time.</li><li>A <a href=\"https://clinicaltrials.gov/ct2/show/NCT03780257?intr=qr-421a&amp;lead=proqr&amp;rank=1\" target=\"_blank\">Phase 1/2 study</a> is in process with a primary completion date in December.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477467\" data-linked=\"ProQR up 13% ahead of QR-421a presentation\" data-tweet=\"$PRQR - ProQR up 13% ahead of QR-421a presentation https://seekingalpha.com/news/3477467-proqr-up-13-ahead-of-qrminus-421a-presentation?source=tweet\" data-url=\"https://seekingalpha.com/news/3477467-proqr-up-13-ahead-of-qrminus-421a-presentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477466\" data-ts=\"1562943715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477466-auto-suppliers-rally-after-tower-takeout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auto suppliers rally after Tower takeout</a></h4><ul> <li>Shares of Tower International (NYSE:<a href='https://seekingalpha.com/symbol/TOWR' title='Tower International, Inc.'>TOWR</a>) are <font color=\"green\">up 68.9%</font> to $30.86 to trail just slightly the <a href=\"https://seekingalpha.com/news/3477415-tower-international-bought-31-share\" target=\"_blank\">$31</a> deal price from  Autokiniton Global Group. On Wall Street, B. Riley FBR tips that Tower could land an even higher offer during the go-shop period.</li>  <li>The deal is lighting a torch under the broad auto parts sector on M&amp;A speculation. Notable gainers include Tenneco (<a href='https://seekingalpha.com/symbol/TEN' title='Tenneco Inc.'>TEN</a> <font color='green'>+9.2%</font>), Visteon (<a href='https://seekingalpha.com/symbol/VC' title='Visteon Corporation'>VC</a> <font color='green'>+4.7%</font>), Cooper-Standard Holdings (<a href='https://seekingalpha.com/symbol/CPS' title='Cooper-Standard Holdings Inc.'>CPS</a> <font color='green'>+5.2%</font>), Lydall (<a href='https://seekingalpha.com/symbol/LDL' title='Lydall, Inc.'>LDL</a> <font color='green'>+5%</font>), Delph Technologies (<a href='https://seekingalpha.com/symbol/DLPH' title='Delphi Technologies PLC'>DLPH</a> <font color='green'>+3.1%</font>), Westport Fuel Systems (<a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems Inc.'>WPRT</a> <font color='green'>+4%</font>), American Axle &amp; Manufacturing (<a href='https://seekingalpha.com/symbol/AXL' title='American Axle & Manufacturing Holdings, Inc.'>AXL</a> <font color='green'>+3.5%</font>), Goodyear Tire &amp; Rubber (<a href='https://seekingalpha.com/symbol/GT' title='The Goodyear Tire & Rubber Company'>GT</a> <font color='green'>+3.6%</font>), Adient (<a href='https://seekingalpha.com/symbol/ADNT' title='Adient plc'>ADNT</a> <font color='green'>+2.7%</font>) and Dana (<a href='https://seekingalpha.com/symbol/DAN' title='Dana Incorporated'>DAN</a> <font color='green'>+2.9%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477466\" data-linked=\"Auto suppliers rally after Tower takeout\" data-tweet=\"$TOWR $TEN $VC - Auto suppliers rally after Tower takeout https://seekingalpha.com/news/3477466-auto-suppliers-rally-after-tower-takeout?source=tweet\" data-url=\"https://seekingalpha.com/news/3477466-auto-suppliers-rally-after-tower-takeout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477464\" data-ts=\"1562943386\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477464-healthcare-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers</a></h4><ul><li><b>Gainers:</b> HOOKIPA Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/HOOK' title='HOOKIPA Pharma Inc.'>HOOK</a>) <font color=\"green\">+23%</font>. Oasmia Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical AB &#40;publ&#41;'>OASM</a>) <font color=\"green\">+19%</font>. Medigus (NASDAQ:<a href='https://seekingalpha.com/symbol/MDGS' title='Medigus Ltd.'>MDGS</a>) <font color=\"green\">+17%</font>. OHR Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/OHRP' title='OHR Pharmaceutical, Inc.'>OHRP</a>) <font color=\"green\">+14%</font>. MediciNova (NASDAQ:<a href='https://seekingalpha.com/symbol/MNOV' title='MediciNova, Inc.'>MNOV</a>) <font color=\"green\">+13%</font>.</li><li><b>Losers:</b> Illumina (NASDAQ:<a href='https://seekingalpha.com/symbol/ILMN' title='Illumina, Inc.'>ILMN</a>) <font color=\"red\">-16%</font>. CannTrust Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CTST' title='CannTrust Holdings Inc.'>CTST</a>) <font color=\"red\">-11%</font>. Co-Diagnostics (NASDAQ:<a href='https://seekingalpha.com/symbol/CODX' title='Co-Diagnostics, Inc.'>CODX</a>) <font color=\"red\">-11%</font>. Agile Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AGRX' title='Agile Therapeutics, Inc.'>AGRX</a>) <font color=\"red\">-10%</font>. Soliton (NASDAQ:<a href='https://seekingalpha.com/symbol/SOLY' title='Soliton, Inc.'>SOLY</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477464\" data-linked=\"Healthcare - Top 5 Gainers / Losers\" data-tweet=\"$HOOK $OASM $MDGS - Healthcare - Top 5 Gainers / Losers https://seekingalpha.com/news/3477464-healthcare-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3477464-healthcare-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477457\" data-ts=\"1562942700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORCL\" target=\"_blank\">ORCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477457-oracle-loses-pentagon-contract-court-case\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oracle loses Pentagon contract court case</a></h4><ul><li>Oracle (NYSE:<a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a>) shares <font color=\"red\">drop 1%</font> after <a href=\"https://www.nextgov.com/it-modernization/2019/07/court-rules-favor-pentagon-jedi-lawsuit/158372/\" target=\"_blank\">reports</a> the company lost its court case against the Pentagon's $10B, winner-takes-all JEDI cloud contract.</li><li>The court ruled in favor of the Department of Defense and Amazon, saying Oracle had not met certain criteria when bids were due.</li><li>The JEDI decision is coming next month. The Pentagon has <a href=\"https://seekingalpha.com/news/3473540-pentagons-cloud-award-coming-august\" target=\"_blank\">confirmed</a> Amazon and Microsoft as the final contenders.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477457\" data-linked=\"Oracle loses Pentagon contract court case\" data-tweet=\"$ORCL - Oracle loses Pentagon contract court case https://seekingalpha.com/news/3477457-oracle-loses-pentagon-contract-court-case?source=tweet\" data-url=\"https://seekingalpha.com/news/3477457-oracle-loses-pentagon-contract-court-case\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477455\" data-ts=\"1562942269\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477455-buckle-rally-extends-to-second-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buckle rally extends to second day</a></h4><ul> <li>Buckle (NYSE:<a href='https://seekingalpha.com/symbol/BKE' title='The Buckle, Inc.'>BKE</a>) is <font color=\"green\">up another 8.7%</font> to add to yesterday's rally.</li> <li>Shares of Buckle are at a two-month high after the retailer posted a 6% same-store sales gain for June.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3477455\" data-linked=\"Buckle rally extends to second day\" data-tweet=\"$BKE - Buckle rally extends to second day https://seekingalpha.com/news/3477455-buckle-rally-extends-to-second-day?source=tweet\" data-url=\"https://seekingalpha.com/news/3477455-buckle-rally-extends-to-second-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477452\" data-ts=\"1562942027\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477452-pg-and-e-pushing-tax-exempt-bond-bill-for-fire-claims-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PG&amp;E pushing tax-exempt bond bill for fire claims - Bloomberg</a></h4><ul><li>PG&amp;E (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color='red'>-3.8%</font>) is lobbying California legislators to allow it to <a href=\"https://finance.yahoo.com/news/pg-e-pushing-tax-exempt-183034073.html\" target=\"_blank\">issue tax-exempt bonds</a> to help pay for past and future wildfire claims, Bloomberg reports.</li><li>PG&amp;E is pushing lawmakers to introduce the legislation next month to allow PG&amp;E to present its $31B restructuring plan by Sept. 26, after which stakeholders could submit competing proposals, according to the report.</li><li>Any bill would need to clear the state's Assembly and Senate by the end of the legislative session on Sept. 13 and then be signed by Gov. Newsom by Oct. 13.</li><li>Under separate legislation <a href=\"https://seekingalpha.com/news/3477286-wildfire-fund-bill-approved-california-lawmakers\" target=\"_blank\">approved yesterday</a>, PG&amp;E and California's other power companies would be able to borrow from a multibillion-dollar fund to pay for future wildfire claims.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477452\" data-linked=\"PG&amp;E pushing tax-exempt bond bill for fire claims - Bloomberg\" data-tweet=\"$PCG - PG&amp;E pushing tax-exempt bond bill for fire claims - Bloomberg https://seekingalpha.com/news/3477452-pg-and-e-pushing-tax-exempt-bond-bill-for-fire-claims-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3477452-pg-and-e-pushing-tax-exempt-bond-bill-for-fire-claims-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477448\" data-ts=\"1562941444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477448-mizuho-lifts-qcom-target-despite-expected-softness\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mizuho lifts QCOM target despite expected softness</a></h4><ul><li>Mizuho says Qualcomm's (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='QUALCOMM Incorporated'>QCOM</a>) top-line results could be at risk due to the FTC ruling. The company will report earnings on July 31.</li><li>Last week, U.S. district Judge Lucy Koh <a href=\"https://www.bloomberg.com/news/articles/2019-07-03/qualcomm-loses-bid-to-pause-antitrust-ruling-in-ftc-lawsuit\" target=\"_blank\">ruled</a> there was no reason to halt the issued injunctions while Qualcomm's appeal is pending.</li><li>Analyst Vijay Rakesh says the ruling \"could potentially challenge the six-year supply agreement with Apple signed in April.\"</li><li>Rakesh expects near-term outlook softness due to weak handsets, multiple OEMs entering re-licensing in H2 and  potentially negotiating lower 5G royalty rates, and the upcoming LGE renegotiation.</li><li>Mizuho maintains a Neutral rating and raises QCOM's target from $65 to $68, citing improved semi multiples and valuations in the past month.</li><li>QCOM shares are up 1.1% to $74.52. The company has an Outperform average <a href=\"https://seekingalpha.com/symbol/QCOM/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477448\" data-linked=\"Mizuho lifts QCOM target despite expected softness\" data-tweet=\"$QCOM - Mizuho lifts QCOM target despite expected softness https://seekingalpha.com/news/3477448-mizuho-lifts-qcom-target-despite-expected-softness?source=tweet\" data-url=\"https://seekingalpha.com/news/3477448-mizuho-lifts-qcom-target-despite-expected-softness\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477446\" data-ts=\"1562941216\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USX\" target=\"_blank\">USX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477446-u-s-xpress-plummets-after-guidance-cut-baml-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S Xpress plummets after guidance cut, BAML downgrade</a></h4><ul> <li>Shares of U.S. Xpress Enterprises (NYSE:<a href='https://seekingalpha.com/symbol/USX' title='U.S. Xpress Enterprises, Inc.'>USX</a>) are <font color=\"red\">down 19.2%</font> after the company lowered its guidance and Bank of America Merrill Lynch downgraded the stock to a Neutral rating from Buy.</li> <li>\"While valuation appears attractive, the lack of progress on its cost goals is concerning, particularly for its ability to manage through cycles,\" warns BAML.</li> <li>\"We expect excess capacity, rate weakness, and reduced demand to negatively impact both revenue and margins in 2Q19 and full-year 2019,\" adds the firm.</li> <li>BAML's price objective on USX goes to $6 from $12 vs. the <a href=\"https://seekingalpha.com/symbol/USX/ratings/sell-side-ratings\" target=\"_blank\">sell-side average</a> PT of $11.20.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3477267-u-s-xpress-minus-3-percent-cutting-guidance\" target=\"_blank\">U.S. Xpress -3% after cutting guidance</a> (July 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3477446\" data-linked=\"U.S Xpress plummets after guidance cut, BAML downgrade\" data-tweet=\"$USX - U.S Xpress plummets after guidance cut, BAML downgrade https://seekingalpha.com/news/3477446-u-s-xpress-plummets-after-guidance-cut-baml-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3477446-u-s-xpress-plummets-after-guidance-cut-baml-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477445\" data-ts=\"1562941091\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COINB\" target=\"_blank\">COINB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477445-crypto-fans-welcome-trumps-no-coiner-remarks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crypto fans welcome Trump&#39;s no-coiner remarks</a></h4><ul><li>\u201cFirst they ignore you, then they laugh at you, then they fight you, then you win,\" <a href=\"https://twitter.com/brian_armstrong/status/1149492705673695232\" target=\"_blank\">says </a>Coinbase (<a href='https://seekingalpha.com/symbol/COINB' title='Coinbase'>COINB</a>) CEO Brian Armstrong. \"We just made it to step 3 y\u2019all.\"</li><li>Armstrong's remarks come after <a href=\"https://seekingalpha.com/news/3477310-president-coiner\" target=\"_blank\">the president last night</a> proclaimed himself not a fan of cryptocurrencies, and specifically called into questions Facebook's Libra offering.</li><li>Armstrong: \"I dreamt about a sitting U.S. president needing to respond to growing cryptocurrency usage years ago.\"</li><li>Bitcoin (<a href='https://seekingalpha.com/symbol/BTC-USD' title='Bitcoin USD'>BTC-USD</a>) is up modestly this morning to $11.7K. Ripple (<a href='https://seekingalpha.com/symbol/XRP-USD' title='XRP USD'>XRP-USD</a>), Ether (<a href='https://seekingalpha.com/symbol/ETH-USD' title='Ethereum USD'>ETH-USD</a>), Litecoin (<a href='https://seekingalpha.com/symbol/LTC-USD' title='Litecoin USD'>LTC-USD</a>), and Bitcoin Cash (<a href='https://seekingalpha.com/symbol/BCH-USD' title='Bitcoin Cash USD'>BCH-USD</a>) are also in the green.</li><li>The Grayscale Bitcoin Trust (<a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a> <font color='green'>+2.1%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3477445\" data-linked=\"Crypto fans welcome Trump&#39;s no-coiner remarks\" data-tweet=\"$COINB $GBTC $COINB - Crypto fans welcome Trump&#39;s no-coiner remarks https://seekingalpha.com/news/3477445-crypto-fans-welcome-trumps-no-coiner-remarks?source=tweet\" data-url=\"https://seekingalpha.com/news/3477445-crypto-fans-welcome-trumps-no-coiner-remarks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>143&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477443\" data-ts=\"1562940771\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FMCC\" target=\"_blank\">FMCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477443-fannie-freddie-swoon-after-massively-diluted-note-from-bove\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fannie, Freddie swoon after `massively diluted&#39; note from Bove</a></h4><ul><li>Fannie Mae (<a href='https://seekingalpha.com/symbol/FNMA' title='Federal National Mortgage Association'>OTCQB:FNMA</a>) <font color=\"red\">slumps 9.9% </font>and Freddie Mac (<a href='https://seekingalpha.com/symbol/FMCC' title='Freddie Mac'>OTCQB:FMCC</a>) <font color=\"red\">falls 9.6% </font>as Odeon strategist Dick Bove notes the GSEs' common equity \"will be massively diluted\" and there's no model in place \"that suggests that this dilution can be overcome,\" he told Bloomberg in an email.</li><li>\"The primary mortgages industry is in deep disarray and this must be fixed before the secondary market becomes a reasonable investment,\u201d he wrote.</li><li>Height Capital Markets initiates Fannie and Freddie common equity at sell, junior preferreds at buy.</li><li>In the past six months Freddie <a href=\"https://seekingalpha.com/symbol/FMCC/momentum/performance?s=fmcc\" target=\"_blank\">has risen 66%</a> and Fannie shares <a href=\"https://seekingalpha.com/symbol/FNMA/momentum/performance?s=fnma\" target=\"_blank\">have jumped 72%</a> as investors expect some progress on restructuring and ending government conservatorship status; compares with financial sector median performance of +4.9%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477443\" data-linked=\"Fannie, Freddie swoon after `massively diluted&#39; note from Bove\" data-tweet=\"$FMCC $FNMA $FNMA - Fannie, Freddie swoon after `massively diluted&#39; note from Bove https://seekingalpha.com/news/3477443-fannie-freddie-swoon-after-massively-diluted-note-from-bove?source=tweet\" data-url=\"https://seekingalpha.com/news/3477443-fannie-freddie-swoon-after-massively-diluted-note-from-bove\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>121&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477439\" data-ts=\"1562940146\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477439-icer-report-cites-continued-lack-of-evidence-supporting-efficacy-of-exon-skipping-therapies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ICER report cites continued lack of evidence supporting efficacy of exon-skipping therapies for DMD</a></h4><ul><li>The Institute for Clinical and Economic Review &#40;ICER&#41;, a Boston-based non-profit that evaluates the cost of medical treatments, has just published an <a href=\"https://icer-review.org/announcements/dmd_evidence_report/\" target=\"_blank\">Evidence Report</a> assessing the comparative clinical benefit and value of Sarepta Therapeutics' (<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a> <font color=\"red\">-0.8%</font>) Exondys 51 (eteplirsen) and golodirsen and PTC Therapeutics' (<a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics, Inc.'>PTCT</a> <font color=\"red\">-1.9%</font>) corticosteroid Emflaza (deflazacort) for the treatment of Duchenne muscular dystrophy &#40;DMD&#41;. The report will be reviewed at a public meeting of the New England Comparative Effectiveness Public Advisory Council in Cambridge, MA on Thursday, July 25.</li><li>The report cites the absence of \"persuasive evidence\" that exon-skipping therapies improve outcomes that matter to patients, including functional status, quality of life or length of life. The limited data that exists show that both drugs modestly increase dystrophin levels but the clinical significance of this is \"uncertain.\"</li><li>As far as cost is concerned (more than $1M/year in its model), eteplirsen would still be over-priced even if it restored DMD patients to perfect health for additional 40 years, adding that it is unable to calculate value-based price benchmarks for either medication due to the paucity of efficacy data.</li><li>It says that there is evidence that deflazacort, a corticosteroid developed years ago, delivers greater benefits with less risk than prednisone, but the U.S. price is way out of line, 50x higher than prices in other countries.</li><li>The value-based price benchmark range is no higher than $19,000 - 31,700 per year. Conceptually, the company would have to discount the wholesale cost as much as 83% to be in line with the model (price assumption: $81,400).</li><li>According to <a href=\"https://endpts.com/icer-update-on-duchenne-drugs-pushes-up-price-estimates-for-exondys-51-emflaza-ahead-of-july-panel-review/\" target=\"_blank\">Endpoints News</a>, representatives from both companies stated that they have not raised the prices of their medications and are unclear on the assumptions ICER used in its calculations.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477439\" data-linked=\"ICER report cites continued lack of evidence supporting efficacy of exon-skipping therapies for DMD\" data-tweet=\"$SRPT $PTCT - ICER report cites continued lack of evidence supporting efficacy of exon-skipping therapies for DMD https://seekingalpha.com/news/3477439-icer-report-cites-continued-lack-of-evidence-supporting-efficacy-of-exon-skipping-therapies?source=tweet\" data-url=\"https://seekingalpha.com/news/3477439-icer-report-cites-continued-lack-of-evidence-supporting-efficacy-of-exon-skipping-therapies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477437\" data-ts=\"1562939822\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477437-mty-food-groupminus-2_4-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MTY Food Group -2.4% post Q2 results</a></h4><ul><li>MTY Food Group (<a href='https://seekingalpha.com/symbol/MTYFF' title='MTY Food Group Inc.'>OTC:MTYFF</a>) reported <a href=\"https://seekingalpha.com/pr/17569944-mty-reports-second-quarter-results\" target=\"_blank\">Q2</a> revenue increase of 21.6% Y/Y to C$130.6M; due to the increase in sales to retail channels and the acquisition of Casa Grecque.</li><li>System sales were up 12% Y/Y reaching $832.3M, primarily attributable to recent acquisitions.</li><li>EBITDA margin <font color=\"red\">declined 530 bps</font> to 26.1% &amp; Normalized EBITDA margin also <font color=\"red\">declined 280 bps</font> to 29.2%.</li><li>MTY's network had 7,345 locations in operation, of which 181 were corporate and 7,164 were franchised.</li><li>Same store sales: Total +0.6%; Canadian +1.4%; Ontario +1.1%; British Columbia +6%; Quebec +1.2% &amp; Maritimes +2.9%.</li><li>The West Coast, which represents 49% of total US system sales, had positive growth of 0.4% and the East Coast continued to see positive growth with a 2.9% increase.</li><li>As at May 31, 2019, the Company had $47.5M of cash on hand, and a LTD of $526.5M in the form of holdbacks on acquisition and bank facilities.</li><li>On May 23, 2019, the company acquired all the outstanding shares of Papa Murphy's for a total consideration of $255.2M.</li><li>The Company also acquired the assets of South Street Burger for a total consideration of ~$5.1M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3477333-mty-food-group-reports-q2-results\" target=\"_blank\">MTY Food Group reports Q2 results</a> (Jul. 12 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3477437\" data-linked=\"MTY Food Group -2.4% post Q2 results\" data-tweet=\"$MTYFF - MTY Food Group -2.4% post Q2 results https://seekingalpha.com/news/3477437-mty-food-groupminus-2_4-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3477437-mty-food-groupminus-2_4-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477436\" data-ts=\"1562939779\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZM\" target=\"_blank\">ZM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477436-stephens-praises-zoom-slack-growth-runways\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stephens praises Zoom, Slack growth runways</a></h4><ul><li>More details out on yesterday afternoon's bullish starts of Zoom (NASDAQ:<a href='https://seekingalpha.com/symbol/ZM' title='Zoom Video Communications, Inc.'>ZM</a>) and Slack (NYSE:<a href='https://seekingalpha.com/symbol/WORK' title='Slack Technologies, Inc.'>WORK</a>) at Stephens.</li><li>Analyst Dmitry Netis says Zoom will \"grow into its premium valuation as it becomes the global standard for enterprises\" and gives it an Overweight rating and Street-high $115 target.</li><li>For Slack, Netis sees a long runway for growth through global expansion, new product launches, and converting more free users to paid customers.</li><li>The analyst sees Slack's roughly 15M MAUs as about 5% of its TAM.</li><li>Slack gets an Overweight rating and a $43 price target.</li><li>SLACK shares are <font color=\"red\">down 2.3%</font> to $34.20 following <a href=\"https://seekingalpha.com/news/3477238-microsoft-passes-slack-daus\" target=\"_blank\">yesterday's news</a> that Microsoft's competing product is attracting more users. ZM shares are <font color=\"green\">up 1.3%</font> to $92.55.</li><li>Average Sell Side ratings put Slack at <a href=\"https://seekingalpha.com/symbol/WORK/ratings/sell-side-ratings\" target=\"_blank\">Outperform</a> and Zoom at <a href=\"https://seekingalpha.com/symbol/ZM/ratings/sell-side-ratings?s=zm\" target=\"_blank\">Hold</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477436\" data-linked=\"Stephens praises Zoom, Slack growth runways\" data-tweet=\"$ZM $ZM $WORK - Stephens praises Zoom, Slack growth runways https://seekingalpha.com/news/3477436-stephens-praises-zoom-slack-growth-runways?source=tweet\" data-url=\"https://seekingalpha.com/news/3477436-stephens-praises-zoom-slack-growth-runways\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477435\" data-ts=\"1562939587\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRED\" target=\"_blank\">FRED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477435-freds-trims-down-to-80-stores\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fred&#39;s trims down to 80 stores</a></h4><ul> <li>Fred's (<a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a> <font color='green'>+2.3%</font>)  announces that it will close an additional 129 retail stores and hold inventory clearance sales across all stores in an effort to refocus its product mix.</li><li>The new round of closings are aimed at simplifying the store portfolio and repay debt.</li>    <li>Fred\u2019s will be down to 80 retail stores remaining following the closings, centered primarily around the distribution center in Dublin, Georgia. Fred's may evaluate re-launching certain closed stores in the future under a new operating model, with an updated assortment.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17570141-fred-s-close-additional-129-stores-hold-inventory-clearance-sales-across-stores\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3477435\" data-linked=\"Fred&#39;s trims down to 80 stores\" data-tweet=\"$FRED - Fred&#39;s trims down to 80 stores https://seekingalpha.com/news/3477435-freds-trims-down-to-80-stores?source=tweet\" data-url=\"https://seekingalpha.com/news/3477435-freds-trims-down-to-80-stores\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477425\" data-ts=\"1562938062\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAM\" target=\"_blank\">SAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477425-guggenheim-sees-upside-on-boston-beer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guggenheim sees upside on Boston Beer</a></h4><ul> <li>Guggenheim is confident on Boston Beer (NYSE:<a href='https://seekingalpha.com/symbol/SAM' title='The Boston Beer Company, Inc.'>SAM</a>) ahead of the beer company's Q2 earnings report.</li> <li>\"We reiterate our BUY on Boston Beer shares given the growth runway ahead driven by Twisted Tea, Truly, and other new innovations. In addition, we see a lower degree of risk associated with the expected future growth given the reduced reliance on new innovations to drive the algorithm and the addition of Dogfish Head,\" notes the firm.</li> <li>Guggenheim's upped price target of $421 is way ahead of the consensus sell-side PT of $290.91 and contrasts with the <a href=\"https://seekingalpha.com/symbol/SAM/ratings/quant-ratings\" target=\"_blank\">Seeking Alpha Quant Rating</a> of Neutral.</li> <li>Shares of SAM are <font color=\"green\">up 2.89%</font> premarket to $393.96.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477425\" data-linked=\"Guggenheim sees upside on Boston Beer\" data-tweet=\"$SAM - Guggenheim sees upside on Boston Beer https://seekingalpha.com/news/3477425-guggenheim-sees-upside-on-boston-beer?source=tweet\" data-url=\"https://seekingalpha.com/news/3477425-guggenheim-sees-upside-on-boston-beer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477421\" data-ts=\"1562937639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477421-rdhl-sfix-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RDHL, SFIX among premarket gainers</a></h4><ul><li>Medigus (NASDAQ:<a href='https://seekingalpha.com/symbol/MDGS' title='Medigus Ltd.'>MDGS</a>) <font color=\"green\">+49%</font> on <a href=\"https://seekingalpha.com/news/3477378-medigus-80-percent-premarket-large-order-visualization-device\" target=\"_blank\">large order</a> for visualization device.</li><li>VivoPower (NASDAQ:<a href='https://seekingalpha.com/symbol/VVPR' title='VivoPower International PLC'>VVPR</a>) <font color=\"green\">+48%</font> on <a href=\"https://seekingalpha.com/news/3477416-vivopower-international-reports-fy-results\" target=\"_blank\">FY result</a>.</li><li>HOOKIPA Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/HOOK' title='HOOKIPA Pharma Inc.'>HOOK</a>) <font color=\"green\">+29%</font> on go with <a href=\"https://seekingalpha.com/news/3477280-hookipa-go-study-hbminus-201-hpv-cancers-shares-37-percent-hours\" target=\"_blank\">study of HB-201</a> in HPV+ cancers.</li><li>Milacron Holdings (NYSE:<a href='https://seekingalpha.com/symbol/MCRN' title='Milacron Holdings Corp.'>MCRN</a>) <font color=\"green\">+23%</font> on being <a href=\"https://seekingalpha.com/news/3477363-hillenbrand-acquire-milacron-2b\" target=\"_blank\">acquired by Hillenbrand</a>.</li><li>Oasmia Pharmaceutical AB (NASDAQ:<a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical AB &#40;publ&#41;'>OASM</a>) <font color=\"green\">+22%</font>.</li><li>Uxin (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin Limited'>UXIN</a>) <font color=\"green\">+10%</font> on <a href=\"https://seekingalpha.com/news/3477406-uxin-divest-loan-facilitation-related-business-golden-pacer-shares-10-percent-premarket\" target=\"_blank\">divesting loan facilitation</a> related business to Golden Pacer.</li><li>Ritter Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RTTR' title='Ritter Pharmaceuticals, Inc.'>RTTR</a>) <font color=\"green\">+7%</font> on <a href=\"https://seekingalpha.com/pr/17569782-ritter-pharmaceuticals-regains-compliance-nasdaq-s-minimum-bid-price-requirement\" target=\"_blank\">regaining compliance with Nasdaq\u2019s</a> minimum bid price requirement.</li><li>Stitch Fix (NASDAQ:<a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a>) <font color=\"green\">+6%</font> after <a href=\"https://seekingalpha.com/news/3477373-stitch-fix-plus-4-percent-goldman-sachs-nod\" target=\"_blank\">Goldman Sachs nod</a>.</li><li>RedHill Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/RDHL' title='RedHill Biopharma Ltd.'>RDHL</a>) <font color=\"green\">+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477421\" data-linked=\"RDHL, SFIX among premarket gainers\" data-tweet=\"$MDGS $VVPR $HOOK - RDHL, SFIX among premarket gainers https://seekingalpha.com/news/3477421-rdhl-sfix-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3477421-rdhl-sfix-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477415\" data-ts=\"1562937162\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOWR\" target=\"_blank\">TOWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477415-tower-international-bought-out-for-31-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tower International bought out for $31/share</a></h4><ul><li>P-E backed Autokiniton Global Group <a href=\"https://seekingalpha.com/pr/17570140-autokiniton-global-group-acquire-tower-international-31-per-share-cash\" target=\"_blank\">agrees to acquire</a> Tower International (NYSE:<a href='https://seekingalpha.com/symbol/TOWR' title='Tower International, Inc.'>TOWR</a>) for $31/share in cash, representing a 70% premium to TOWR's closing stock price yesterday.</li><li>Including TOWR's debt and pension related liabilities, the total transaction is valued at ~$900M.</li><li>TOWR <font color=\"green\">+68.5%</font> pre-market.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477415\" data-linked=\"Tower International bought out for $31/share\" data-tweet=\"$TOWR - Tower International bought out for $31/share https://seekingalpha.com/news/3477415-tower-international-bought-out-for-31-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3477415-tower-international-bought-out-for-31-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477414\" data-ts=\"1562937148\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477414-ilmn-hi-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ILMN, HI among premarket losers</a></h4><ul><li>EMCORE (NASDAQ:<a href='https://seekingalpha.com/symbol/EMKR' title='EMCORE Corporation'>EMKR</a>) <font color=\"red\">-18%</font> on <a href=\"https://seekingalpha.com/news/3477288-emcore-minus-12-percent-preliminary-q3-weakness\" target=\"_blank\">preliminary Q3</a> weakness.</li><li>Illumina (NASDAQ:<a href='https://seekingalpha.com/symbol/ILMN' title='Illumina, Inc.'>ILMN</a>) <font color=\"red\">-15%</font> on <a href=\"https://seekingalpha.com/news/3477256-illumina-15-percent-hours-softer-guidance\" target=\"_blank\">softer guidance</a>.</li><li>SenesTech (NASDAQ:<a href='https://seekingalpha.com/symbol/SNES' title='SenesTech, Inc.'>SNES</a>) <font color=\"red\">-15%</font> on <a href=\"https://seekingalpha.com/news/3477312-senestech-prices-common-stock-offering\" target=\"_blank\">pricing</a> stock offering.</li><li>Hillenbrand (NYSE:<a href='https://seekingalpha.com/symbol/HI' title='Hillenbrand, Inc.'>HI</a>) <font color=\"red\">-14%</font> on <a href=\"https://seekingalpha.com/news/3477363-hillenbrand-acquire-milacron-2b\" target=\"_blank\">announcing</a> acquisition of Milacron for $2B.</li><li>Co-Diagnostics (NASDAQ:<a href='https://seekingalpha.com/symbol/CODX' title='Co-Diagnostics, Inc.'>CODX</a>) <font color=\"red\">-13%</font>.</li><li>CannTrust Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CTST' title='CannTrust Holdings Inc.'>CTST</a>) <font color=\"red\">-11%</font> after <a href=\"https://seekingalpha.com/news/3477368-canntrust-holds-product-sales-shares-18-percent-premarket\" target=\"_blank\">holding</a> product sales.</li><li>Innovative Industrial Properties (NYSE:<a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties, Inc.'>IIPR</a>) <font color=\"red\">-8%</font> on <a href=\"https://seekingalpha.com/news/3477254-innovative-industrial-starts-capital-raise\" target=\"_blank\">announcing</a> stock offering.</li><li>Foresight Autonomous Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a>) <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477414\" data-linked=\"ILMN, HI among premarket losers\" data-tweet=\"$EMKR $ILMN $SNES - ILMN, HI among premarket losers https://seekingalpha.com/news/3477414-ilmn-hi-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3477414-ilmn-hi-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477411\" data-ts=\"1562936482\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CL\" target=\"_blank\">CL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477411-colgate-palmolives-m-move-draws-praise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Colgate-Palmolive&#39;s M&amp;A move draws praise</a></h4><ul> <li>New Colgate-Palmolive (NYSE:<a href='https://seekingalpha.com/symbol/CL' title='Colgate-Palmolive Company'>CL</a>) Noel Wallace has struck quickly with a deal to buy luxury cosmetics player Laboratoires Filorga Cosmétiques for around $1.7B.</li> <li>Colgate-Palmolive execs aren't making the media rounds to talk up the upside on the transaction due to the pre-earnings quiet period, but analysts are buzzing.</li> <li>\"This is a clear sign that Wallace will be more aggressive with M&amp;A to reshape the portfolio outside of Oral Care, a big change for a company that has historically been run very conservatively,\" notes Wells Fargo's Bonnie Herzog.</li> <li>Bernstein's Ali Dibadj likes the move by Colgate into a higher margin category.</li> <li>While the deal is drawing praise from the sell side, no firm has jumped in with an upgrade or price target boost (<a href=\"https://seekingalpha.com/symbol/CL/ratings/sell-side-ratings\" target=\"_blank\">sell-side consensus</a>: Hold, $72.48 PT) just yet.</li><li>Colgate struck the deal after seeing recently-acquired skin care brands PCA Skin and EltaMD help to boost earnings.</li> <li>Shares of CL are <font color=\"red\">down 0.87%</font> premarket to $73.25.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477411\" data-linked=\"Colgate-Palmolive&#39;s M&amp;A move draws praise\" data-tweet=\"$CL - Colgate-Palmolive&#39;s M&amp;A move draws praise https://seekingalpha.com/news/3477411-colgate-palmolives-m-move-draws-praise?source=tweet\" data-url=\"https://seekingalpha.com/news/3477411-colgate-palmolives-m-move-draws-praise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477402\" data-ts=\"1562934671\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MS\" target=\"_blank\">MS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477402-citi-goes-bullish-on-morgan-stanley-cuts-six-banks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi goes bullish on Morgan Stanley; cuts six other banks</a></h4><ul><li>Morgan Stanley (NYSE:<a href='https://seekingalpha.com/symbol/MS' title='Morgan Stanley'>MS</a>)<font color=\"green\"> gains 1.4%</font> in premarket trading after Citi <a href=\"https://www.marketbeat.com/ratings/USA/latest/\" target=\"_blank\">upgrades</a> to buy from neutral.</li><li>Cuts Comerica (NYSE:<a href='https://seekingalpha.com/symbol/CMA' title='Comerica Incorporated'>CMA</a>), Northern Trust (NASDAQ:<a href='https://seekingalpha.com/symbol/NTRS' title='Northern Trust Corporation'>NTRS</a>), and M&amp;T Bank (NYSE:<a href='https://seekingalpha.com/symbol/MTB' title='M&T Bank Corporation'>MTB</a>) to sell from neutral.</li><li>Comerica<font color=\"green\"> </font><font color=\"red\">falls 0.7%</font>, M&amp;T Bank <font color=\"red\">slips 0.1%</font>.</li><li>Cuts Wells Fargo (NYSE:<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Company'>WFC</a>), Citizens Financial Group (NYSE:<a href='https://seekingalpha.com/symbol/CFG' title='Citizens Financial Group, Inc.'>CFG</a>), and Fifth Third (NASDAQ:<a href='https://seekingalpha.com/symbol/FITB' title='Fifth Third Bancorp'>FITB</a>) to neutral from buy.</li><li>Citizens Financial <font color=\"red\">-0.7%</font>.</li><li>Morgan Stanley quant rating <a href=\"https://seekingalpha.com/symbol/MS/ratings/quant-ratings\" target=\"_blank\">Very Bullish</a>; Sell-Side average rating <a href=\"https://seekingalpha.com/symbol/MS/ratings/sell-side-ratings\" target=\"_blank\">Outperform </a>(14 Buy, 7 Outperform, Hold 5, Underperform 1). Peer stats <a href=\"https://seekingalpha.com/symbol/MS/peers/comparison\" target=\"_blank\">comparison</a>.</li><li>Peer s<a href=\"https://seekingalpha.com/symbol/CMA/peers/comparison?s=cma\" target=\"_blank\">tats comparison</a> for CMA, MTB, CFG, FITB.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477402\" data-linked=\"Citi goes bullish on Morgan Stanley; cuts six other banks\" data-tweet=\"$MS $CMA $NTRS - Citi goes bullish on Morgan Stanley; cuts six other banks https://seekingalpha.com/news/3477402-citi-goes-bullish-on-morgan-stanley-cuts-six-banks?source=tweet\" data-url=\"https://seekingalpha.com/news/3477402-citi-goes-bullish-on-morgan-stanley-cuts-six-banks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477365\" data-ts=\"1562933484\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDHL\" target=\"_blank\">RDHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477365-oppenheimer-likes-fate-therapeutics-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer likes Fate Therapeutics in premarket analyst action</a></h4><ul><li>Fate Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/FATE' title='Fate Therapeutics, Inc.'>FATE</a>) initiated with Outperform rating and $27 (32% upside) price target at Oppenheimer. Shares up <font color=\"green\">3%</font> premarket.</li><li>RedHill Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/RDHL' title='RedHill Biopharma Ltd.'>RDHL</a>) upgraded to Strong Buy with a $17 (156% upside) at WBB Securities.</li><li>Rhythm Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RYTM' title='Rhythm Pharmaceuticals, Inc.'>RYTM</a>) upgraded to Buy with a $34 (65% upside) price target at Stifel ahead a Phase 3 data on setmelanotide in POMC deficiency obesity and LEPR deficiency obesity.</li><li>CannTrust (TRST CN) downgraded to Sell with a C$4 (flat) price target at Eight Capital.</li><li>Illumina (NASDAQ:<a href='https://seekingalpha.com/symbol/ILMN' title='Illumina, Inc.'>ILMN</a>) downgraded to Underperform with a $290 (20% downside risk) at BofA/Merrill Lynch after the company cut 2019 revenue guidance. Shares down <font color=\"red\">15%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477365\" data-linked=\"Oppenheimer likes Fate Therapeutics in premarket analyst action\" data-tweet=\"$RDHL $FATE $RYTM - Oppenheimer likes Fate Therapeutics in premarket analyst action https://seekingalpha.com/news/3477365-oppenheimer-likes-fate-therapeutics-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3477365-oppenheimer-likes-fate-therapeutics-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477388\" data-ts=\"1562932956\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDE\" target=\"_blank\">CDE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477388-coeur-minings-q2-shows-double-digit-production-gains-across-all-metals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coeur Mining&#39;s Q2 shows double-digit production gains across all metals</a></h4><ul><li>Coeur Mining (NYSE:<a href='https://seekingalpha.com/symbol/CDE' title='Coeur Mining, Inc.'>CDE</a>) <font color=\"green\">+5.2%</font> pre-market after reporting <a href=\"https://seekingalpha.com/pr/17569700-coeur-reports-second-quarter-2019-production-sales-results\" target=\"_blank\">Q2 production</a> of 86.6K oz. of gold, 3.1M oz. of silver, 5.3M lbs. of zinc and 5M lbs. of lead.</li><li>\"Operational results were in-line with our expectations and reflect solid, double-digit production increases across all four metals we produce,\" says CDE President and CEO Mitchell Krebs.</li><li>CDE says Q2 gold and silver production at the Palmarejo mine in Mexico rose 22% and 36% Q/Q, respectively, to 28.2K and 1.7M oz., citing higher throughput and recovery rates.</li><li>Q2 silver, zinc and lead production at the Silvertip mine in British Columbia jumped a respective 44%, 43% and  62% Q/Q to 300 oz. of silver, 5.3M lbs. of zinc and 5M lbs. of lead.</li><li>CDE reaffirms total full-year production guidance of 334K-372K oz. of gold, 12.2M-14.7M oz. of silver, 25M-40M lbs. of zinc and 20M-35M lbs. of lead.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477388\" data-linked=\"Coeur Mining&#39;s Q2 shows double-digit production gains across all metals\" data-tweet=\"$CDE - Coeur Mining&#39;s Q2 shows double-digit production gains across all metals https://seekingalpha.com/news/3477388-coeur-minings-q2-shows-double-digit-production-gains-across-all-metals?source=tweet\" data-url=\"https://seekingalpha.com/news/3477388-coeur-minings-q2-shows-double-digit-production-gains-across-all-metals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477386\" data-ts=\"1562932805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LK\" target=\"_blank\">LK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477386-luckin-coffee-looks-to-tea\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Luckin Coffee looks to tea</a></h4><ul> <li>Luckin Coffee (NASDAQ:<a href='https://seekingalpha.com/symbol/LK' title='Luckin Coffee Inc.'>LK</a>) <a href=\"https://www.barrons.com/articles/chinas-starbucks-luckin-coffee-is-selling-tea-it-wont-be-easy-51562930737\" target=\"_blank\">launched</a> a new line of tea drinks in China today in an effort to diversify its products line.</li> <li>Luckin's tea drinks are listed at prices about 25% below than those at Starbucks and are anticipated to generate margins about 25% lower than coffee for the company.</li> <li>Luckin plans to give out free drinks and discounts to lure customers to the tea brand.</li> <li>Shares of LK are <font color=\"green\">up 0.31%</font> premarket to $19.55 vs. the post-IPO range of $13.71 to $25.96.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477386\" data-linked=\"Luckin Coffee looks to tea\" data-tweet=\"$LK - Luckin Coffee looks to tea https://seekingalpha.com/news/3477386-luckin-coffee-looks-to-tea?source=tweet\" data-url=\"https://seekingalpha.com/news/3477386-luckin-coffee-looks-to-tea\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477378\" data-ts=\"1562931670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDGS\" target=\"_blank\">MDGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477378-medigus-up-80-premarket-on-large-order-for-visualization-device\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medigus up 80% premarket on large order for visualization device</a></h4><ul><li>Ultra-thinly traded nano cap Medigus Ltd. (NASDAQ:<a href='https://seekingalpha.com/symbol/MDGS' title='Medigus Ltd.'>MDGS</a>) is up <font color=\"green\">80% </font>premarket on robust volume in reaction to its <a href=\"https://seekingalpha.com/pr/17569937-medigus-receives-first-substantial-commercial-order-integrated-visualization-device\" target=\"_blank\">announcement</a> that A.M. Surgical has placed an order for 1,400 units of its integrated visualization device that A.M. will pair with its endoscopic surgical product.</li><li>Medigus says it will receive $650K for the order.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477378\" data-linked=\"Medigus up 80% premarket on large order for visualization device\" data-tweet=\"$MDGS - Medigus up 80% premarket on large order for visualization device https://seekingalpha.com/news/3477378-medigus-up-80-premarket-on-large-order-for-visualization-device?source=tweet\" data-url=\"https://seekingalpha.com/news/3477378-medigus-up-80-premarket-on-large-order-for-visualization-device\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477376\" data-ts=\"1562931194\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIMX\" target=\"_blank\">HIMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477376-himaxminus-1_5-roth-hits-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Himax -1.5% as Roth hits sidelines</a></h4><ul><li>Roth downgrades Himax (NASDAQ:<a href='https://seekingalpha.com/symbol/HIMX' title='Himax Technologies, Inc.'>HIMX</a>) from Buy to Neutral and trims the target from $5 to $3.50, implying a 5% upside.</li><li>HIMX has a Hold average <a href=\"https://seekingalpha.com/symbol/HIMX/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a> out of six analyst ratings.</li><li>Himax shares are <font color=\"red\">down 1.5%</font> pre-market to $3.30.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477376\" data-linked=\"Himax -1.5% as Roth hits sidelines\" data-tweet=\"$HIMX - Himax -1.5% as Roth hits sidelines https://seekingalpha.com/news/3477376-himaxminus-1_5-roth-hits-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3477376-himaxminus-1_5-roth-hits-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477374\" data-ts=\"1562931083\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477374-sell-side-cant-get-enough-snap\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sell-side can&#39;t get enough Snap</a></h4><ul><li>Goldman Sachs is the latest to jump into the hot-handed name, upgrading this morning to Buy from Neutral.</li><li>No details are available, but <a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>'s nearly tripled in price this year. Enough said.</li><li>Shares are <font color=\"green\">up another 3.3%</font> in premarket action.</li><li>Even with this upgrade and a number of others over the last month, the <a href=\"https://seekingalpha.com/symbol/SNAP/ratings/sell-side-ratings\" target=\"_blank\">Sell-side average rating</a> on Snap remains a Hold. The <a href=\"https://seekingalpha.com/symbol/SNAP/ratings/author-ratings\" target=\"_blank\">SA average author rating</a> is modestly bearish.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477374\" data-linked=\"Sell-side can&#39;t get enough Snap\" data-tweet=\"$SNAP - Sell-side can&#39;t get enough Snap https://seekingalpha.com/news/3477374-sell-side-cant-get-enough-snap?source=tweet\" data-url=\"https://seekingalpha.com/news/3477374-sell-side-cant-get-enough-snap\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477373\" data-ts=\"1562931074\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFIX\" target=\"_blank\">SFIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477373-stitch-fixplus-4-after-goldman-sachs-nod\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stitch Fix +4% after Goldman Sachs nod</a></h4><ul> <li>Stitch Fix (NASDAQ:<a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a>) races higher in early trading after Goldman Sachs moves to a Buy rating on the online retailer after having it slotted at Neutral.</li> <li>Goldman assigns a price target of $38 to SFIX vs. the <a href=\"https://seekingalpha.com/symbol/SFIX/ratings/sell-side-ratings\" target=\"_blank\">sell-side average PT</a> of $36.00.</li> <li>Shares of Stitch Fix are <font color=\"green\">up 4.27%</font> premarket to $29.32. vs. the 52-week trading range of $16.05 to $52.44.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477373\" data-linked=\"Stitch Fix +4% after Goldman Sachs nod\" data-tweet=\"$SFIX - Stitch Fix +4% after Goldman Sachs nod https://seekingalpha.com/news/3477373-stitch-fixplus-4-after-goldman-sachs-nod?source=tweet\" data-url=\"https://seekingalpha.com/news/3477373-stitch-fixplus-4-after-goldman-sachs-nod\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477368\" data-ts=\"1562930436\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTST\" target=\"_blank\">CTST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477368-canntrust-holds-product-sales-shares-down-18-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CannTrust holds product sales; shares down 18% premarket</a></h4><ul> <li>CannTrust Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CTST' title='CannTrust Holdings Inc.'>CTST</a>) has implemented a <a href=\"https://seekingalpha.com/pr/17569858-canntrust-voluntary-hold-product-sales-formation-independent-special-committee-board\" target=\"_blank\">voluntary hold</a> on sale and shipment of all cannabis products as a precaution while Health Canada visits and reviews its Vaughan, Ontario manufacturing facility.</li>                  <li>The hold was placed through customer service line and online as of 11:59 p.m. on July 10.</li>     <li>Also, a Special Committee of the Board of Directors has been established to investigate this matter in its entirety.</li><li>Shares are down <font color=\"red\">18%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477368\" data-linked=\"CannTrust holds product sales; shares down 18% premarket\" data-tweet=\"$CTST - CannTrust holds product sales; shares down 18% premarket https://seekingalpha.com/news/3477368-canntrust-holds-product-sales-shares-down-18-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3477368-canntrust-holds-product-sales-shares-down-18-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477367\" data-ts=\"1562930413\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFY\" target=\"_blank\">INFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477367-infosys-raises-revenue-outlook-buybacks-sharesplus-3_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infosys raises revenue outlook, buybacks; shares +3.5%</a></h4><ul><li>Infosys (NYSE:<a href='https://seekingalpha.com/symbol/INFY' title='Infosys Limited'>INFY</a>) <font color=\"green\">gains 3.5% </font>after a <a href=\"https://seekingalpha.com/news/3477348-infosys-eps-line-misses-revenue\" target=\"_blank\">Q1 report</a> that missed revenue estimates and met on EPS. Digital revenues grew 42% Y/Y to $1.1B.</li><li>FY20 outlook: Infosys increases its revenue growth guidance range to 8.5-10% and maintains the operating margin outlook of 21-23%.</li><li>Capital allocation: INFY revises its current policy of returning up to 70% of FCF annually to shareholders through dividends and/or buybacks. Starting in FY20, the number will increase to 85% of FCF cumulatively for a five-year period.</li><li><a href=\"https://www.infosys.com/investors/reports-filings/quarterly-results/2019-2020/q1/Documents/IFRS-USD-press-release.pdf\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477367\" data-linked=\"Infosys raises revenue outlook, buybacks; shares +3.5%\" data-tweet=\"$INFY - Infosys raises revenue outlook, buybacks; shares +3.5% https://seekingalpha.com/news/3477367-infosys-raises-revenue-outlook-buybacks-sharesplus-3_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3477367-infosys-raises-revenue-outlook-buybacks-sharesplus-3_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477360\" data-ts=\"1562929867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDY\" target=\"_blank\">RDY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477360-dr-reddys-slips-1-premarket-after-fda-citations-manufacturing-site\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dr. Reddy&#39;s slips 1% premarket after FDA citations at manufacturing site</a></h4><ul><li>Dr. Reddy's Laboratories (NYSE:<a href='https://seekingalpha.com/symbol/RDY' title='Dr. Reddy&#39;s Laboratories Limited'>RDY</a>) is down <font color=\"red\">1%</font> premarket on light volume on the heels of an <a href=\"https://www.moneycontrol.com/news/business/usfda-issues-5-observations-to-dr-reddys-plant-in-hyderabad-4199321.html\" target=\"_blank\">FDA audit</a> at its Hyderabad Plant #2 that resulted in five observations although the nature of the citations, issued on a Form 483, are not disclosed (could be relatively minor).</li></ul><div class=\"tiny-share-widget\" data-id=\"3477360\" data-linked=\"Dr. Reddy&#39;s slips 1% premarket after FDA citations at manufacturing site\" data-tweet=\"$RDY - Dr. Reddy&#39;s slips 1% premarket after FDA citations at manufacturing site https://seekingalpha.com/news/3477360-dr-reddys-slips-1-premarket-after-fda-citations-manufacturing-site?source=tweet\" data-url=\"https://seekingalpha.com/news/3477360-dr-reddys-slips-1-premarket-after-fda-citations-manufacturing-site\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477359\" data-ts=\"1562929806\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PNM\" target=\"_blank\">PNM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477359-mildest-q2-in-19-years-prompts-guidance-cut-pnm-resources\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mildest Q2 in 19 years prompts guidance cut at PNM Resources</a></h4><ul><li>PNM Resources (NYSE:<a href='https://seekingalpha.com/symbol/PNM' title='PNM Resources, Inc.'>PNM</a>) <font color=\"red\">-3.7%</font> pre-market after <a href=\"https://seekingalpha.com/pr/17569952-pnm-resources-revises-2019-earnings-guidance-management-meet-investors\" target=\"_blank\">cutting its profit outlook</a> for Q2 and the full year, saying its service territory experienced its mildest Q2 in 19 years.</li><li>PNM now sees Q2 EPS of $0.36-$0.38, well below both previous guidance of $0.57-$0.59 and analyst consensus of $0.62, and lowers FY 2019 EPS guidance to $2.05-$2.11 from $2.10 to $2.20, vs. $2.15 consensus.</li><li>PNM provides electricity to 781K homes and businesses in New Mexico and west Texas.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477359\" data-linked=\"Mildest Q2 in 19 years prompts guidance cut at PNM Resources\" data-tweet=\"$PNM - Mildest Q2 in 19 years prompts guidance cut at PNM Resources https://seekingalpha.com/news/3477359-mildest-q2-in-19-years-prompts-guidance-cut-pnm-resources?source=tweet\" data-url=\"https://seekingalpha.com/news/3477359-mildest-q2-in-19-years-prompts-guidance-cut-pnm-resources\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477357\" data-ts=\"1562929703\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MO\" target=\"_blank\">MO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477357-altriaplus-2-after-goldman-sachs-lift\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altria +2% after Goldman Sachs lift</a></h4><ul> <li>Goldman Sachs lifts Altria (NYSE:<a href='https://seekingalpha.com/symbol/MO' title='Altria Group, Inc.'>MO</a>) to a Buy rating from Neutral on a valuation call.</li> <li>The firm assigns a price target of $59 to the tobacco stock vs. the <a href=\"https://seekingalpha.com/symbol/MO/ratings/sell-side-ratings\" target=\"_blank\">sell-side average PT</a> of $58.41.</li> <li>Shares of MO are <font color=\"green\">up 1.93%</font> in premarket trading vs. the 52-week trading range of $42.40 to $66.04.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477357\" data-linked=\"Altria +2% after Goldman Sachs lift\" data-tweet=\"$MO - Altria +2% after Goldman Sachs lift https://seekingalpha.com/news/3477357-altriaplus-2-after-goldman-sachs-lift?source=tweet\" data-url=\"https://seekingalpha.com/news/3477357-altriaplus-2-after-goldman-sachs-lift\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>52&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477351\" data-ts=\"1562928885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNOV\" target=\"_blank\">MNOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477351-medicinova-readies-late-stage-study-of-mnminus-166-in-progressive-ms\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MediciNova readies late-stage study of MN-166 in progressive MS</a></h4><ul><li>Subsequent to FDA feedback, MediciNova (NASDAQ:<a href='https://seekingalpha.com/symbol/MNOV' title='MediciNova, Inc.'>MNOV</a>) has <a href=\"https://seekingalpha.com/pr/17569848-medicinova-announces-phase-3-clinical-trial-plan-mnminus-166-ibudilast-progressive-ms\" target=\"_blank\">finalized the protocol</a> for a Phase 3 clinical trial evaluating MN-166 (ibudilast) in patients with secondary progressive multiple sclerosis &#40;MS&#41; without relapses.</li><li>The primary endpoint will be the time to three-month confirmed disability progression as measured by a scale called EDSS, the same endpoint used for other drugs approved for progressive MS.</li><li>The agency indicated that one study may be sufficient to support a marketing application.</li><li>The size of the study and its projected start date are not provided.</li><li><strong>Update</strong>: Shares are up <font color=\"green\">9%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477351\" data-linked=\"MediciNova readies late-stage study of MN-166 in progressive MS\" data-tweet=\"$MNOV - MediciNova readies late-stage study of MN-166 in progressive MS https://seekingalpha.com/news/3477351-medicinova-readies-late-stage-study-of-mnminus-166-in-progressive-ms?source=tweet\" data-url=\"https://seekingalpha.com/news/3477351-medicinova-readies-late-stage-study-of-mnminus-166-in-progressive-ms\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477348\" data-ts=\"1562928360\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFY\" target=\"_blank\">INFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477348-infosys-eps-in-line-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infosys EPS in-line, misses on revenue</a></h4><ul><li>Infosys (NYSE:<a href='https://seekingalpha.com/symbol/INFY' title='Infosys Limited'>INFY</a>): Q1 GAAP EPS of $0.13 in-line.</li><li>Revenue of $3.13B (+10.6% Y/Y) <font color=\"red\">misses by $30M</font>.</li><li>Shares <font color=\"green\">+4.58%</font> PM.</li><li><a href=\"https://www.infosys.com/investors/reports-filings/quarterly-results/2019-2020/q1/Documents/IFRS-USD-press-release.pdf\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3477348\" data-linked=\"Infosys EPS in-line, misses on revenue\" data-tweet=\"$INFY - Infosys EPS in-line, misses on revenue https://seekingalpha.com/news/3477348-infosys-eps-in-line-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3477348-infosys-eps-in-line-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477341\" data-ts=\"1562926843\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477341-futures-extend-gains-dow-holds-27k\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Futures extend gains as Dow holds 27K</a></h4><ul><li>The Dow rallied 200 points on Thursday to close above 27,000 for the first time ever as Fed Chair Jerome Powell cemented his view that rates have room to go lower in the coming months.</li><li>\"We're learning that interest rates - that the neutral interest rate - is lower than we had thought and I think we're learning that the natural rate of unemployment is lower than we thought,\" Powell said in the second day of semi-annual testimony on Capitol Hill. \"So monetary policy hasn't been as accommodative as we had thought.\"</li><li>Futures contracts tied to the DJIA are extending gains, <font color=\"green\">up 89 points</font> ahead of the open, while the S&amp;P 500 and Nasdaq are <font color=\"green\">ahead by 0.3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477341\" data-linked=\"Futures extend gains as Dow holds 27K\" data-tweet=\"Futures extend gains as Dow holds 27K https://seekingalpha.com/news/3477341-futures-extend-gains-dow-holds-27k?source=tweet\" data-url=\"https://seekingalpha.com/news/3477341-futures-extend-gains-dow-holds-27k\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477334\" data-ts=\"1562925984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTST\" target=\"_blank\">CTST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477334-canntrust-suspends-cannabis-product-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CannTrust suspends cannabis product sales</a></h4><ul><li>CannTrust (NYSE:<a href='https://seekingalpha.com/symbol/CTST' title='CannTrust Holdings Inc.'>CTST</a>) is <a href=\"https://www.thestreet.com/markets/5-things-you-must-know-before-the-market-opens-friday-15016204\" target=\"_blank\">suspending</a> sales and shipments of all of its cannabis products and said it was appointing a committee of independent directors to investigate problems at the company.</li><li>The sales and shipment suspension will continue \"while Health Canada visits and reviews its Vaughan, Ontario manufacturing facility,\" CannTrust said in a statement.</li><li>Canadian authorities earlier this week found the company's greenhouse facility in Pelham, Ontario to be \"non-compliant.\"</li><li>CTST <font color=\"red\">-12.9%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3477334\" data-linked=\"CannTrust suspends cannabis product sales\" data-tweet=\"$CTST - CannTrust suspends cannabis product sales https://seekingalpha.com/news/3477334-canntrust-suspends-cannabis-product-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3477334-canntrust-suspends-cannabis-product-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477321\" data-ts=\"1562920012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDAIF\" target=\"_blank\">DDAIF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477321-daimler-skids-on-latest-profit-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Daimler skids on latest profit warning</a></h4><ul><li>Daimler (<a href='https://seekingalpha.com/symbol/DDAIF' title='Daimler AG'>OTCPK:DDAIF</a>) has <a href=\"https://www.bloomberg.com/news/articles/2019-07-12/daimler-cuts-outlook-again-blaming-takata-airbag-diesel-issues\" target=\"_blank\">issued</a> its fourth profit warning in just over a year, this time blaming higher costs to deal with a recall of vehicles fitted with faulty Takata airbags and increasing funds set aside to address diesel emissions-tampering allegations.</li><li>As a result, second-quarter profits will likely swing to a loss of \u20ac1.6B, excluding interest and taxes, a near 40% plunge from the same period last year.</li><li>Full year earnings are also expected to be \"significantly\" below the previous year's levels, sending Daimler shares <font color=\"red\">down as much as 4.5%</font> in Frankfurt.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477321\" data-linked=\"Daimler skids on latest profit warning\" data-tweet=\"$DDAIF $DMLRY - Daimler skids on latest profit warning https://seekingalpha.com/news/3477321-daimler-skids-on-latest-profit-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3477321-daimler-skids-on-latest-profit-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":62,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}